
Peptides
Peptides are short chains of amino acids linked by peptide bonds, serving as important biological molecules that play key roles in cellular processes. They function as hormones, neurotransmitters, and signaling molecules, and are widely used in therapeutic and diagnostic applications. Peptides are also crucial in research for studying protein interactions, enzyme activities, and cell signaling pathways. At CymitQuimica, we provide a diverse selection of high-quality peptides to support your research and development needs in biotechnology and pharmaceuticals.
Subcategories of "Peptides"
Products of "Peptides"
Sort by
H-SEGATPQDL-OH
Peptide H-SEGATPQDL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-SEGATPQDL-OH include the following: Discovery of novel targets for multi-epitope vaccines: Screening of HIV-1 genomes using association rule mining S Paul , H Piontkivska - Retrovirology, 2009 - Springerhttps://link.springer.com/article/10.1186/1742-4690-6-62 Identification of dominant optimal HLA-B60-and HLA-B61-restricted cytotoxic T-lymphocyte (CTL) epitopes: rapid characterization of CTL responses by enzyme-linked MA Altfeld, A Trocha, RL Eldridge - Journal of , 2000 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.74.18.8541-8549.2000 Supplemental Table 1. List of HIV class I peptides. M End - pdfs.semanticscholar.orghttps://pdfs.semanticscholar.org/ed0f/0f087694817c860c5aad97fab618403c2847.pdf HIV-1-specific CD4+ T-cell responses are not associated with significant viral epitope variation in persons with persistent plasma viremia JR Koeppe, TB Campbell, EL Rapaport - JAIDS Journal of , 2006 - journals.lww.comhttps://journals.lww.com/jaids/fulltext/2006/02010/HIV_1_Specific_CD4__T_Cell_Responses_Are_Not.3.aspx Patient-Specific Cytotoxic T-Lymphocyte Cross-Recognition of Naturally Occurring Variants of a Human Immunodeficiency Virus Type 1 (HIV-1) p24gagEpitope by F Buseyne, ML Chaix, C Rouzioux, S Blanche - Journal of , 2001 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.75.10.4941-4946.2001 Variable HIV peptide stability in human cytosol is critical to epitope presentation and immune escape E Lazaro, C Kadie , P Stamegna - The Journal of , 2011 - Am Soc Clin Investighttps://www.jci.org/articles/view/44932CDC27 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CDC27 antibody, catalog no. 70R-4087Purity:Min. 95%H-VVGADGVGK-OH
Peptide H-VVGADGVGK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-VVGADGVGK-OH include the following: Identification of T-cell receptors targeting KRAS-mutated human tumors QJ Wang, Z Yu, K Griffith, K Hanada, NP Restifo - Cancer immunology , 2016 - AACRhttps://aacrjournals.org/cancerimmunolres/article-abstract/4/3/204/468486 Identification and Validation of T-cell Receptors Targeting RAS Hotspot Mutations in Human Cancers for Use in Cell-based Immunotherapy N Levin , BC Paria, NR Vale, R Yossef , FJ Lowery - Clinical Cancer , 2021 - AACRhttps://aacrjournals.org/clincancerres/article-abstract/27/18/5084/671639 Facts and hopes in immunotherapy strategies targeting antigens derived from KRAS mutations GP Linette, AS Bear , BM Carreno - Clinical Cancer Research, 2024 - AACRhttps://aacrjournals.org/clincancerres/article/doi/10.1158/1078-0432.CCR-23-1212/733759H-TNLESILSYPK^-OH
Peptide H-TNLESILSYPK^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-TNLESILSYPK^-OH include the following: a type 1 diabetes study [version 1; referees: peer review W Zhi, S Purohit , S Bai, A Sharma , JX She - Citeseerhttps://citeseerx.ist.psu.edu/document?repid=rep1&type=pdf&doi=2686966456451cca9367c60562eada514b3baa82 Selective degradation of serum proteins is likely responsible for the spurious differences in innate immunity proteins observed in a type 1 diabetes study W Zhi , S Purohit , S Bai, A Sharma , JX She - F1000Research, 2014 - f1000research.comhttps://f1000research.com/articles/3-237 Serum proteomics reveals systemic dysregulation of innate immunity in type 1 diabetes Q Zhang , TL Fillmore, AA Schepmoes - Journal of Experimental , 2013 - rupress.orghttps://rupress.org/jem/article-abstract/210/1/191/41276H-SNIHVVNEWIANDISSTK-OH
Peptide H-SNIHVVNEWIANDISSTK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-SNIHVVNEWIANDISSTK-OH include the following: Characterization of recombinant human nicotinamide mononucleotide adenylyl transferase (NMNAT), a nuclear enzyme essential for NAD synthesis M Schweiger, K Hennig, F Lerner, M Niere - FEBS , 2001 - Wiley Online Libraryhttps://febs.onlinelibrary.wiley.com/doi/abs/10.1016/S0014-5793(01)02180-9Peptide 74
CAS:Peptide 74 is a synthetic peptide. It also inhibits the activated form of this enzyme.Formula:C62H107N23O20S2Purity:98%Color and Shape:SolidMolecular weight:1558.79Ethyl 1-tert-Butoxycarbonyl-4-oxo-3-piperidinecarboxylate
CAS:Formula:C13H21NO5Purity:>97.0%(HPLC)(N)Color and Shape:White to Yellow powder to crystalMolecular weight:271.31H-ASLEDLGWADWVLSPR^-OH
Peptide H-ASLEDLGWADWVLSPR^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-ASLEDLGWADWVLSPR^-OH include the following: Protection of beta cells against pro-inflammatory cytokine stress by the GDF15-ERBB2 signaling S Sarkar , F Syed , BJ Webb-Robertson , JT Melchior - medRxiv, 2023 - medrxiv.orghttps://www.medrxiv.org/content/10.1101/2023.11.27.23298904.abstractL-Homophenylalanine
CAS:Formula:C10H13NO2Purity:>98.0%(T)Color and Shape:White to Almost white powder to crystalMolecular weight:179.22Click PR9
Cell penetrating peptides (CPP) can transport molecules such as nucleic acids, proteins, and imaging agents into cells of interest. Pas PR9, nona-arginine, is an arginine rich CPP. It is composed of the nona-arginine: R9 and Pas which is a peptide penetrating accelerating sequence (PAS) and it functions to export molecules out of endocytic vesicles. During a study in which PR9 was in complex with a Quantum dot probe (QD) it was evident that the PR9/QD complex was transported into the cell through endocytosis and co-localises with actins, lysosomes, early endosomes and the nucleus. Due to the non-toxicity of the PR9/QD complex it can be used as a safe vector for biomedical purposes.PR9 is provided here with a N-terminal alkyne attachment. Two of the most regularly encountered functional groups for click chemistry are azides and alkynes, and the azide-alkyne cycloaddition has become the most popular click reaction. The use of click chemistry with alkyne- PR9 allows a wide variety of applications particularly for conjugation, modification, and peptide design.Color and Shape:PowderMolecular weight:2,304.4 g/molH-IRHENRMVL-OH
Peptide H-IRHENRMVL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-IRHENRMVL-OH include the following: Computational analysis of proteome of H5N1 avian influenza virus to define T cell epitopes with vaccine potential R Parida, MS Shaila, S Mukherjee , NR Chandra - Vaccine, 2007 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X07009772 Towards the knowledge-based design of universal influenza epitope ensemble vaccines QM Sheikh, D Gatherer, PA Reche , DR Flower - Bioinformatics, 2016 - academic.oup.comhttps://academic.oup.com/bioinformatics/article-abstract/32/21/3233/2415119 Towards the Knowledge-based Design of Universal Influenza Epitope Ensemble Vaccines PA Reche Gallardo, QM Sheikh, D Gatherer - 2016 - docta.ucm.eshttps://docta.ucm.es/entities/publication/47f8a2c3-b6a9-4413-b23d-3e3d4005a982 Deciphering HLA-I motifs across HLA peptidomes improves neo-antigen predictions and identifies allostery regulating HLA specificity M Bassani-Sternberg , C Chong - PLoS computational , 2017 - journals.plos.orghttps://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1005725 Development of a self-assembling protein nanoparticle vaccine targeting Plasmodium falciparum Circumsporozoite Protein delivered in three Army Liposome L Seth, KMB Ferlez, SA Kaba, DM Musser, S Emadi - Vaccine, 2017 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X17302438 A Wider and Deeper Peptide-Binding Groove for the Class I Molecules from B15 Compared with B19 Chickens Correlates with Relative Resistance to Marek's L Han, S Wu, T Zhang, W Peng, M Zhao - The Journal of , 2023 - journals.aai.orghttps://journals.aai.org/jimmunol/article/210/5/668/237710Velmupressin
CAS:Peptidic V2R agonist, c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-d-Arg-NEt2, with EC50: 0.07 nM (hV2R), 0.02 nM (rV2R); selective, short-acting.Formula:C42H60ClN11O8S2Purity:98%Color and Shape:SolidMolecular weight:946.58Tripeptide-32
CAS:Tripeptide-32 is a bioactive peptide recognized for its anti-aging properties, commonly utilized as an ingredient in cosmetics [1].Formula:C12H22N4O5Purity:98%Color and Shape:SolidMolecular weight:302.33Camostat Mesilate
CAS:Camostat mesilate is a prodrug that is metabolized to the active form, pemastatin. It is used for the treatment of bowel disease and squamous cell carcinoma. Camostat mesilate inhibits the TNF-α receptor by binding to its response element in vitro and in vivo. The biological properties of camostat mesilate are due to its ability to inhibit TNF-α production by binding to the TNF-α receptor, thereby preventing activation of transcription factors such as nuclear factor kappa B (NFκB). In vitro assays have shown that camostat mesilate induces apoptosis in human carcinoma cell lines through inhibition of growth factor-β1. This drug has also been shown to be effective in treating viral infections, including HIV and herpes zoster.Formula:C20H22N4O5•CH3SO3HPurity:Min. 95%Molecular weight:494.5 g/molN-terminally acetylated Leu-enkephalin acetate
N-terminally acetylated Leu-enkephalin is the N-terminally acetylated form of Leu-enkephalin.Formula:C30H39N5O8Purity:98%Color and Shape:SolidMolecular weight:N/APhoenixin-20
CAS:Phoenixin-20 (PNX-20) is a vertebrate bioactive peptide exhibiting hormone-like actions, stimulating the hypothalamo-pituitary-gonadal axis to regulateFormula:C101H153N25O29Purity:98%Color and Shape:SolidMolecular weight:2181.45γ-Glu-Tyr
CAS:gamma-Glu-Tyr (gamma-Glutamyltyrosine) is a kokumi peptide against dipeptidyl peptidase-IV (DPP-IV) and is used in the study of diabetes mellitus.Formula:C14H18N2O6Purity:98.92%Color and Shape:SolidMolecular weight:310.3H-ARVYEIKCR-OH
Peptide H-ARVYEIKCR-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-ARVYEIKCR-OH include the following: Immune evasion proteins of human cytomegalovirus do not prevent a diverse CD8+ cytotoxic T-cell response in natural infection TJ Manley, L Luy, T Jones, M Boeckh , H Mutimer - Blood, 2004 - ashpublications.orghttps://ashpublications.org/blood/article-abstract/104/4/1075/18423 Ex Vivo Profiling of CD8+-T-Cell Responses to Human Cytomegalovirus Reveals Broad and Multispecific Reactivities in Healthy Virus Carriers R Elkington, S Walker, T Crough, M Menzies - Journal of , 2003 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.77.9.5226-5240.2003SS18L1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SS18L1 antibody, catalog no. 70R-3569Purity:Min. 95%Kcnt1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of Kcnt1 antibody, catalog no. 70R-8820Purity:Min. 95%Z-His-Phe-OH
CAS:Please enquire for more information about Z-His-Phe-OH including the price, delivery time and more detailed product information at the technical inquiry form on this pageFormula:C23H24N4O5Purity:Min. 95%Molecular weight:436.46 g/molH-CSVTCG-OH
Peptide H-CSVTCG-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-CSVTCG-OH include the following: Human microvascular endothelial cells adhere to thrombospondin-1 via an RGD/CSVTCG domain independent mechanism ZS Chen, J Pohl , TJ Lawley, RA Swerlick - Journal of investigative , 1996 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0022202X15424303 Identification of SVTCG in thrombospondin as the conformation-dependent, high affinity binding site for its receptor, CD36 WX Li, RJ Howard , LL Leung - Journal of Biological Chemistry, 1993 - ASBMBhttps://www.jbc.org/article/S0021-9258(19)85403-0/abstract Structure and Function of Thrombospondins W Frazier - Trends in Glycoscience and Glycotechnology, 1992 - jstage.jst.go.jphttps://www.jstage.jst.go.jp/article/tigg1989/4/16/4_16_152/_article/-char/ja/ The localization of thrombospondin-1 (TSP-1), cysteine-serine-valine-threonine-cysteine-glycine (CSVTCG) TSP receptor, and matrix metalloproteinase-9 T Wakiyama, T Shinohara, T Shirakusa - Histology and , 2001 - hh.um.eshttps://www.hh.um.es/pdf/Vol_16/16_2/The%20localization%20of%20thrombospondin-1.pdf a Motif Shared by the Malaria Circumsporozoite Protein and Thrombospondin is Mediated Exclusively by its Glycosaminoglycan-Binding Region and Not by CSVTCG SM Gantt , P Clavijo, X Baic, J Esko - may be from any type of , 2000 - search.proquest.comhttps://search.proquest.com/openview/62ac16a7ea361a737bcf29c2fb6e2573/1.pdf?pq-origsite=gscholar&cbl=18750&diss=y#page=58 adhesion to a motif shared by the malaria circumsporozoite protein and thrombospondin is mediated by its glycosaminoglycan-binding region and not by CSVTCG SM Gantt , P Clavijo, X Bai, JD Esko, P Sinnis - Journal of Biological , 1997 - ASBMBhttps://www.jbc.org/article/S0021-9258(18)38944-0/abstract Plasmodium falciparum-infected erythrocyte adhesion to the type 3 repeat domain of thrombospondin-1 is mediated by a modified band 3 protein S Eda, J Lawler , IW Sherman - Molecular and biochemical parasitology, 1999 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0166685199000584 A conserved peptide sequence of the Plasmodium falciparum circumsporozoite protein and antipeptide antibodies inhibit Plasmodium berghei sporozoite invasion of S Chatterjee, M Wery, P Sharma - Infection and , 1995 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/iai.63.11.4375-4381.1995 Histidine-rich glycoprotein inhibits the antiangiogenic effect of thrombospondin-1 R Simantov , M Febbraio , R Crombie - The Journal of , 2001 - Am Soc Clin Investighttps://www.jci.org/articles/view/9061 Identification of cell adhesive active sites in the N-terminal domain of thrombospondin-1 P CLEZARDIN , J LAWLER , J AMIRAL - Biochemical , 1997 - portlandpress.comhttps://portlandpress.com/biochemj/article-abstract/321/3/819/34171 Heparin-and sulfatide-binding peptides from the type I repeats of human thrombospondin promote melanoma cell adhesion. N Guo, HC Krutzsch, E Negre, T Vogel - Proceedings of the , 1992 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.89.7.3040 Identification of active peptide sequences in the carboxyl-terminal cell binding domain of human thrombospondin-1. MD Kosfeld, WA Frazier - Journal of Biological Chemistry, 1992 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0021925818419904 Cell attachment activity of the carboxyl-terminal domain of human thrombospondin expressed in Escherichia coli. MD Kosfeld, TV Pavlopoulos, WA Frazier - Journal of Biological Chemistry, 1991 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0021925818542228 THE 1998 MOYER AWARD Characteristics of Thrombospondin-1 and Its Cysteine-Serine-Valine-Threonine-Cysteine-Glycine Receptor in Burn Wounds JJ Roth, WB Hughes, FA DeClement - Journal of Burn Care , 1998 - academic.oup.comhttps://academic.oup.com/jbcr/article-abstract/19/6/487/4757981 Localization of thrombospondin-1 and its cysteine-serine-valine-threonine-cysteine-glycine receptor in colonic anastomotic healing tissue JJ Roth, MA Buckmire, RH Rolandelli - Histology and , 1998 - hh.um.eshttps://www.hh.um.es/pdf/Vol_13/13_4/Localization%20of%20thrombospondin-l%20and%20its%20cysteine-serine-valine-threonine-cysteine-glycine%20recept.pdf Thrombospondin 1 and its specific cysteine-serine-valine-threonine-cysteine-glycine receptor in fetal wounds JJ Roth, JJ Sung, MS Granick , MP Solomon - Annals of plastic , 1999 - journals.lww.comhttps://journals.lww.com/annalsplasticsurgery/abstract/1999/05000/Thrombospondin_1_and_Its_Specific.16.aspx A CD36-binding peptide from thrombospondin-1 can stimulate resorption by osteoclasts in vitro JA Carron, SC Wagstaff, JA Gallagher - and biophysical research , 2000 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006291X00925749 Cloning and characterization of angiocidin, a tumor cell binding protein for thrombospondin-1 J Zhou, VL Rothman, I Sargiannidou - Journal of cellular , 2004 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/jcb.20076 Cloning and characterization of CSVTCG-specific receptor of thrombospondin-1 J Zhou - 2002 - search.proquest.comhttps://search.proquest.com/openview/4936bad0f3ba407c917959e11d28a4ba/1?pq-origsite=gscholar&cbl=18750&diss=y Thrombin-stimulated calcium mobilization is inhibited by thrombospondin via CD36 J Enenstein, K Gupta, GM Vercellotti - Experimental cell research, 1998 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0014482797938635 The Functional Significance of the CSVTCG-Specific Receptor in Breast Carcinoma Progression I Sargiannidou , G Tuszynski - 2002., 2002 - apps.dtic.milhttps://apps.dtic.mil/sti/citations/tr/ADA405490 Identification and characterization of a tumor cell receptor for CSVTCG, a thrombospondin adhesive domain. GP Tuszynski, VL Rothman, M Papale - The Journal of cell , 1993 - rupress.orghttps://rupress.org/jcb/article-abstract/120/2/513/14638 Biological activities of peptides and peptide analogues derived from common sequences present in thrombospondin, properdin, and malarial proteins. GP Tuszynski, VL Rothman, AH Deutch - The Journal of cell , 1992 - rupress.orghttps://rupress.org/jcb/article-abstract/116/1/209/14270 Stimulation of platelet activation and aggregation by a carboxyl-terminal peptide from thrombospondin binding to the integrin-associated protein receptor DJ Dorahy, RF Thorne, JV Fecondo - Journal of Biological , 1997 - ASBMBhttps://www.jbc.org/article/S0021-9258(19)77610-8/abstract Angiocidin inhibitory peptides decrease tumor burden in a murine colon cancer model C Liebig, N Agarwal, GE Ayala , G Verstovsek - Journal of Surgical , 2007 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0022480407001163 77: Inhibition of angiocidin by two novel peptides decreases tumor burden in an orthotopic nude mouse model C Liebig, N Agarwal, G Ayala - Journal of , 2007 - journalofsurgicalresearch.comhttps://www.journalofsurgicalresearch.com/article/S0022-4804(06)00707-4/abstract Inhibition of Angiogenesis by the First Type I Repeat Peptides of Thrombospondin-1 BI Yoo, GB Jeong - Korean Journal of Physical Anthropology, 2015 - e-aba.orghttps://e-aba.org/DOIx.php?id=10.11637/kjpa.2015.28.4.223 Thrombospondins as anti-angiogenic therapeutic agents B Vailh, JJ Feige - Current pharmaceutical design, 2003 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/cpd/2003/00000009/00000007/art00008 Human platelet glycoprotein IIIb binds to thrombospondin fragments bearing the C-terminal region, and/or the type I repeats (CSVTCG motif), but not to the N B Catimel, L Leung , H El Ghissasi, N Mercier - Biochemical , 1992 - portlandpress.comhttps://portlandpress.com/biochemj/article-abstract/284/1/231/37093 Thrombospondin sequence motif (CSVTCG) is responsible for CD36 binding AS Asch, S Silbiger, E Heimer, RL Nachman - Biochemical and biophysical , 1992 - Elsevierhttps://www.sciencedirect.com/science/article/pii/0006291X9291860S INTERACTIONS OF THROMBOSPONDIN WITH CELLS A PART - Thrombospondin, 1993 - books.google.comhttps://books.google.com/books?hl=en&lr=&id=Hanf7fhm_tsC&oi=fnd&pg=PA91&dq=(%22H-CSVTCG-OH%22+OR+%22CSVTCG%22+OR+%22NH2-Cys-Ser-Val-Thr-Cys-Gly-OH%22)+AND+peptide&ots=5QKzsRxT-P&sig=rdbLm8_Kg3vhMNQEczanw_NjVTIGNPDA1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of GNPDA1 antibody, catalog no. 70R-3271Purity:Min. 95%H-EQLTPLIK-OH
Peptide H-EQLTPLIK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-EQLTPLIK-OH include the following: On-column trypsin digestion coupled with LC-MS/MS for quantification of apolipoproteins CA Toth, Z Kuklenyik, JI Jones, BA Parks - Journal of , 2017 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1874391916304225 Individual glycation sites as biomarkers of type 2 diabetes mellitus A Soboleva, N Vashurina, A Frolov - Type, 2021 - books.google.comhttps://books.google.com/books?hl=en&lr=&id=87dFEAAAQBAJ&oi=fnd&pg=PA63&dq=(%22NH2-Glu-Gln-Leu-Thr-Pro-Leu-Ile%5ELys-OH%22+OR+%22EQLTPLIK%22+OR+%22EQLTPLI%5EK%22+OR+%22H-EQLTPLIK-OH%22+OR+%22H-EQLTPLI%5EK-OH%22)+AND+peptide&ots=B0IVtalzjh&sig=W6GW5nygi23Tt79TCakMYl6wuIs Individual glycation sites as biomarkers of type 2 diabetes mellitus A Soboleva, N Vashurina, A Frolov - Type, 2021 - books.google.comhttps://books.google.com/books?hl=en&lr=&id=87dFEAAAQBAJ&oi=fnd&pg=PA63&dq=(%22NH2-Glu-Gln-Leu-Thr-Pro-Leu-Ile%5ELys-OH%22+OR+%22EQLTPLIK%22+OR+%22EQLTPLI%5EK%22+OR+%22H-EQLTPLIK-OH%22+OR+%22H-EQLTPLI%5EK-OH%22)+AND+peptide&ots=B0IVtalAce&sig=up-bTP6z0cT9ob8y5PwJKPutUB4Caloxin 1C2
Plasma membrane calcium pumps (PMCA) play integral roles in calcium homeostasis and calcium signalling. There are four PMCA isoforms (1-4), their expression and localisation are varied amongst cell types and diseased tissue. Therefore, identification of specific inhibitors of each PMCA is underway to aid understanding of the individual roles the PMCAs play. Use of phage libraries and mutagenesis has allowed rapid screening of possible peptides. A PMCA inhibitor of importance found by screening and mutagenesis is caloxin 1C2. Caloxin 1C2 has been shown to have a 10 found higher affinity for PMCA4 than any other isoforms suggesting it is a suitable selective inhibitor for PMCA4 activity. The allosteric inhibitor is already being used in research to help understand the specific function of PMCA4 in tissues. Since changes in the levels of activity and expression of the PMCA isoforms have been linked to several conditions, such as hypertension and diabetes, clarifying the function of PMCA4 with the use of caloxin1C2 inhibitor could provide new treatments in the future.Color and Shape:PowderMolecular weight:1,843 g/molPDE1C Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PDE1C antibody, catalog no. 70R-2073Purity:Min. 95%SERPINB6 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SERPINB6 antibody, catalog no. 70R-9715Purity:Min. 95%Benzoic acid, 5-amino-2-nitro-
CAS:Formula:C7H6N2O4Purity:95%Color and Shape:SolidMolecular weight:182.13354PKCβII Peptide Inhibitor I
CAS:PKCβII Peptide Inhibitor I, a specific PKCβII inhibitor, exhibits cardioprotective properties in a rat cardiac ischemia/reperfusion injury model and mitigatesFormula:C61H94N12O19Purity:98%Color and Shape:SolidMolecular weight:1299.47Ac-[Pro18, Asp21] beta-Amyloid (17-21), amide, iAb5p Pro18 Asp21
Catalogue peptide; min. 95% purityFormula:C35H46N6O8Molecular weight:678.79 g/molH-AVYNFATCG-OH
Peptide H-AVYNFATCG-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-AVYNFATCG-OH include the following: Design of high-affinity major histocompatibility complex-specific antagonist peptides that inhibit cytotoxic T-lymphocyte activity: implications for control of viral disease JE Gairin, MB Oldstone - Journal of virology, 1992 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.66.11.6755-6762.1992GUK1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of GUK1 antibody, catalog no. 70R-2009Purity:Min. 95%H-FYDPLAGK-OH
Peptide H-FYDPLAGK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-FYDPLAGK-OH include the following: TNF-alpha and IL-1beta Exposure Modulates the Expression and Functionality of P-Glycoprotein in Intestinal and Renal Barriers S Saib, S Hodin, C Mercier, M Paul, V Bin - Molecular , 2022 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.2c00140 Impact of In Vitro Passive Permeability in a P-gp-transfected LLC-PK1 Model on the Prediction of the Rat and Human Unbound Brain-to-Plasma Concentration Ratio J Nicolaaca¯ , H Chapy, E Gillent, K Saunders - Pharmaceutical , 2020 - Springerhttps://link.springer.com/article/10.1007/s11095-020-02867-z Value of quantifying ABC transporters by mass spectrometry and impact on in vitro-to-in vivo prediction of transporter-mediated drug-drug interactions of rivaroxaban E Jacqueroux, S Hodin, S Saib, Z He , V Bin - European Journal of , 2020 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0939641120300060 Assessment of brain delivery of a model ABCB1/ABCG2 substrate in patients with non-contrast-enhancing brain tumors with positron emission tomography B Wulkersdorfer, M Bauer , R Karch, H Stefanits - EJNMMI research, 2019 - Springerhttps://link.springer.com/article/10.1186/s13550-019-0581-yEPGN Human
EPGN Human is a research tool that is an activator, ligand, and receptor. It is also used in Cell Biology as an antibody and an ion channel. EPGN Human is used in pharmacology as a peptide. EPGN Human has high purity and can be used in Life Science for protein interactions or as an inhibitor.Purity:Min. 95%Hp1404
Antimicrobial peptides (AMP) are proving a lucrative area for antibiotics in the era of bacterial resistance. Of note, the scorpion Heterometrus petersii was found to produce Hp1404, an amphipathic cationic peptide with specific activity against Gram-positive bacteria- Hp1404 was shown to be effective against methicillin-resistant Staphylococcus aureus (MRSA). The mode of action is by membrane penetration and disruption. MRSA did not gain resistance after several exposures to Hp1404 suggesting it may be a key agent against the rise of antibiotic resistance. Importantly, bacterial lethality was maintained with low toxicity to mammalian cells. Hp1404 is being used to generate analogues with reduced toxicity to mammalian cells and improved antimicrobial potency against a wider range of organisms.Color and Shape:PowderMolecular weight:1,544.9 g/molPhenylthiohydantoin-proline
CAS:Formula:C12H12N2OSPurity:>98.0%(HPLC)(N)Color and Shape:White to Almost white powder to crystalMolecular weight:232.30Risuteganib hydrochloride
Risuteganib hydrochloride is an anti-integrin for dry AMD, targeting three receptors to reduce oxidative stress and restore retinal balance.Formula:C22H40ClN9O11SPurity:98%Color and Shape:SolidMolecular weight:674.122-Chlorotrityl Chloride Resin (200-400 mesh) 1% DVB
2-Chlorotrityl Chloride Resin (200-400 mesh) 1% DVB is a resin that is used as a building block for peptide synthesis. It can be used to synthesize the building blocks for peptides, including amino acids, alcohols and amines. 2-Chlorotrityl Chloride Resin (200-400 mesh) 1% DVB has been shown to react with thiols, alcohols and amines in solution to form covalent bonds. It can also be used as a tool in the synthesis of thiols, alcohols or amines.Purity:Min. 95%PSA1 (141-150)
CAS:This Prostate Specific Antigen 1 peptide was used in the immunotherapy of cancer experiments.Formula:C55H93N13O13SPurity:98%Color and Shape:SolidMolecular weight:1176.47H-CSLYQLENY-OH
Peptide H-CSLYQLENY-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-CSLYQLENY-OH include the following: Purification and characterization of two extracellular proteases with unusual peptide bond specificity from Xanthomonas campestris pv. malvacearum JL Huang - 1992 - shareok.orghttps://shareok.org/bitstream/handle/11244/13486/Thesis-1992-H874p.pdf?sequence=1TLQP-21
CAS:TLQP 21, a VGF-derived peptide, guards CGCs against apoptosis and combats early diet-induced diabetes by boosting energy spend.Formula:C107H170N40O26Purity:98%Color and Shape:SolidMolecular weight:2432.75ABCB8 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ABCB8 antibody, catalog no. 70R-6464Purity:Min. 95%MAGEA6 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of MAGEA6 antibody, catalog no. 70R-3558Purity:Min. 95%H-EFNNLER-OH
Peptide H-EFNNLER-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-EFNNLER-OH include the following: Limited tryptic digestion-isotope dilution mass spectrometry (LTD-IDMS): A reagent-free analytical assay to quantify hemagglutinin of A (H5N1) vaccine material HC Cooper, Y Xie, G Palladino, JR Barr - Analytical , 2020 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.analchem.0c02252TPCN1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of TPCN1 antibody, catalog no. 70R-5158Purity:Min. 95%OTUB1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of OTUB1 antibody, catalog no. 70R-3802Purity:Min. 95%H-APQPELPYPQPGS-OH
Peptide H-APQPELPYPQPGS-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-APQPELPYPQPGS-OH include the following: Template-based peptide modeling for celiac risk assessment of newly expressed proteins in GM crops P Song, Z Hou, S Sukumar, RA Herman - Regulatory Toxicology and , 2020 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0273230020301410Anti Basic-FGF (1-9), human Serum
Anti Basic-FGF (1-9) is a peptide that has been shown to inhibit the growth of cancer cells in vitro. It is an activator of the receptor tyrosine kinase FGF receptor and has been used as a research tool for studying the interactions between proteins. The antibody against Anti Basic-FGF (1-9) can be used in immunohistochemistry and Western blot analysis to identify this peptide in tissue samples. This peptide is also an inhibitor of the ion channel protein, TRPM4, and has been shown to block its activity at low concentrations.Purity:Min. 95%ZNF486 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF486 antibody, catalog no. 70R-9107Purity:Min. 95%H-TANDLNLLILR^-OH
Peptide H-TANDLNLLILR^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-TANDLNLLILR^-OH include the following: Multi-target detection of nuts and peanuts as hidden allergens in bakery products through bottom-up proteomics and high-resolution mass spectrometry A Luparelli, I Losito , E De Angelis, R Pilolli, L Monaci - Foods, 2023 - mdpi.comhttps://www.mdpi.com/2304-8158/12/4/726 Secure food-allergen determination by combining smartphone-based raw image analyses and liquid chromatography-mass spectrometry for the quantification of JLD Nelis , S Moddejongen, X Guan- Analytical ..., 2022 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.analchem.2c03000 High-resolution mass spectrometry-based selection of peanut peptide biomarkers considering food processing and market type variation M Gavage , K Van Vlierberghe, C Van Poucke - Food chemistry, 2020 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0308814619315432 MRM3-based LC-MS multi-method for the detection and quantification of nut allergens R Korte, J Brockmeyer - Analytical and bioanalytical chemistry, 2016 - Springerhttps://link.springer.com/article/10.1007/s00216-016-9888-y Global proteomic screening of protein allergens and advanced glycation endproducts in thermally processed peanuts CM Hebling, MA McFarland, JH Callahan- Journal of agricultural ..., 2013 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/jf303554t マルãƒã‚¢ãƒ¬ãƒ«ã‚²ãƒ³ã®æ¤œå‡º J Sealey-Voyksner, D ImmungenX, R Voyksner- chem-agilent.comhttps://www.chem-agilent.com/appnote/pdf/low_5991-6095JAJP.pdfH-NAIIK^-OH
Peptide H-NAIIK^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-NAIIK^-OH include the following: Opioid and tachykinin neuropeptides in prolactin-secreting human pituitary adenomas X Zhu, JT Robertson, HS Sacks, FC Dohan Jr - Peptides, 1995 - Elsevierhttps://www.sciencedirect.com/science/article/pii/019697819500081T Peptide quantification by tandem mass spectrometry X Zhu, DM Desiderio - Mass spectrometry reviews, 1996 - Wiley Online Libraryhttps://analyticalsciencejournals.onlinelibrary.wiley.com/doi/abs/10.1002/(SICI)1098-2787(1996)15:4%3C213::AID-MAS1%3E3.0.CO;2-L beta-Endorphin-Containing Proteins in the Human Pituitary L Yan, X Zhu, JL Tseng, DM Desiderio - Peptides, 1997 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0196978197002076 Detection and characterization of native beta-endorphin1-31 in bovine pituitary using electrospray ionization, liquid secondary ion and tandem mass spectrometry L Yan, JL Tseng, DM Desiderio - Journal of Mass Spectrometry, 1995 - Wiley Online Libraryhttps://analyticalsciencejournals.onlinelibrary.wiley.com/doi/abs/10.1002/jms.1190300403 Mass spectrometric measurement of beta-endorphin and methionine enkephalin in human pituitaries. Tumors and post-mortem controls JJ Kusmierz, C Dass, JT Robertson - International journal of , 1991 - Elsevierhttps://www.sciencedirect.com/science/article/pii/016811769185058T Quantitative analysis of methionine enkephalin and beta-endorphin in the pituitary by liquid secondary ion mass spectrometry and tandem mass spectrometry DM Desiderio, X Zhu - Journal of Chromatography A, 1998 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0021967397006705 Mass spectrometric analysis of opioid and tachykinin neuropeptides in non-secreting and ACTH-secreting human pituitary adenomas DM Desiderio, JJ Kusmierz, X Zhu - Biological mass , 1993 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/bms.1200220112 Mass spectrometry, high performance liquid chromatography, and brain peptides DM Desiderio - Peptide Science, 1996 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/(SICI)1097-0282(1996)40:3%3C257::AID-BIP1%3E3.0.CO;2-V Minireview quantitative analytical mass spectrometry of endogenous neuropeptides in human pituitaries DM Desiderio - Life sciences, 1992 - Elsevierhttps://www.sciencedirect.com/science/article/pii/002432059290072W Mass spectrometric analysis of neuropeptidergic systems in the human pituitary and cerebrospinal fluid DM Desiderio - Journal of Chromatography B: Biomedical Sciences , 1999 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0378434799001723 Analysis of endogenous neuropeptides by reversed-phase high-performance chromatography and mass spectrometry DM Desiderio - Analytica chimica acta, 1997 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0003267097001347 Mass spectrometric quantification of endogenous beta-endorphin C Dass, JJ Kusmierz - Biological mass , 1991 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/bms.1200200306 Characterization of beta-endorphin in human pituitary by fast atom bombardment mass spectrometry of trypsin-generated fragments C DASS, GH FRIDLAND, PW TINSLEY - journal of peptide , 1989 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1399-3011.1989.tb01494.xMMEL1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of MMEL1 antibody, catalog no. 70R-6249Purity:Min. 95%[Gln8]-C517 (LH-RH), chicken acetate
Avian peptide [Gln8]-C517 (LH-RH) triggers gonadotropin release, regulating reproduction.Formula:C56H75N15O16Purity:99.83%Color and Shape:SolidMolecular weight:1214.31NT 13 acetate
NT 13 acetate is a partial agonist of NMDA receptor and can be used for research on depression, anxiety, and other related diseases.Formula:C20H34N4O9Purity:98%Color and Shape:SolidMolecular weight:474.51H-NIDGYFK^-OH
Peptide H-NIDGYFK^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-NIDGYFK^-OH include the following: Ultrafast analysis of peptides by laser diode thermal desorption-triple quadrupole mass spectrometry PA Segura , C Guillaumain, E Eysseric - Rapid , 2022 - Wiley Online Libraryhttps://analyticalsciencejournals.onlinelibrary.wiley.com/doi/abs/10.1002/rcm.9373 Mass spectrometry approaches for SARS-CoV-2 detection: harnessing for application in food and environmental samples E Bojorquez-Velazquez , ML Llamas-GarcacaÂa - Viruses, 2022 - mdpi.comhttps://www.mdpi.com/1999-4915/14/5/872H-DITPTLTLYVGK^-OH
Peptide H-DITPTLTLYVGK^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-DITPTLTLYVGK^-OH include the following: Comparative plasma proteome analysis of lymphoma-bearing SJL mice VB Bhat , MH Choi , JS Wishnok - Journal of proteome , 2005 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/pr0501463Cpne5 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of Cpne5 antibody, catalog no. 70R-9505Purity:Min. 95%H-LGANAILGVSMAAAR-OH
Peptide H-LGANAILGVSMAAAR-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-LGANAILGVSMAAAR-OH include the following: Analysis of protein methylation in the Saccharomyces cerevisiae cell-cycle SZ Chia - 2011 - unsworks.unsw.edu.auhttps://unsworks.unsw.edu.au/entities/publication/e6ecfdae-f116-4c42-8cea-d1313efd8a48 Strategic proteome analysis of Candida magnoliae with an unsequenced genome HJ Kim, DY Lee , DH Lee , YC Park , DH Kweon - , 2004 - Wiley Online Libraryhttps://analyticalsciencejournals.onlinelibrary.wiley.com/doi/abs/10.1002/pmic.200400966Lamin B Receptor Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of LBR antibody, catalog no. 70R-6757Purity:Min. 95%2-Hydroxy-5-methoxyisoindoline-1,3-dione
CAS:Formula:C9H7NO4Purity:>98.0%(T)(HPLC)Color and Shape:White to Light yellow powder to crystalMolecular weight:193.16H-LLFNK^VTLA-OH
Peptide H-LLFNK^VTLA-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-LLFNK^VTLA-OH include the following: Leveraging the immunoinformatics approach for designing the SARS-CoV-2 omicron-specific antigenic cassette of mRNA vaccine R Wadapurkar , S Singh, A Singh - Vaccine, 2024 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X24001117 Structural Analysis and Epitope Prediction of S2 Domain of SARS-CoV-2, Conservation Analysis Among Major Variants F Noor, R Nawaz , A Ahad, A Ajmal, S Abrar - Viral , 2023 - liebertpub.comhttps://www.liebertpub.com/doi/abs/10.1089/vim.2022.0101 Immunoinformatic analysis of T-and B-cell epitopes for SARS-CoV-2 vaccine design D Wang, J Mai, W Zhou, W Yu, Y Zhan, N Wang - Vaccines, 2020 - mdpi.comhttps://www.mdpi.com/2076-393X/8/3/355H-PVNFKLLSH-OH
Peptide H-PVNFKLLSH-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-PVNFKLLSH-OH include the following: Pepcan-12 (RVD-hemopressin) is a CB2 receptor positive allosteric modulator constitutively secreted by adrenals and in liver upon tissue damage V Petrucci, A Chicca , S Glasmacher, J Paloczi , Z Cao - Scientific reports, 2017 - nature.comhttps://www.nature.com/articles/s41598-017-09808-8 Characterization of pepcan-23 as pro-peptide of RVD-hemopressin (pepcan-12) and stability of hemopressins in mice S Glasmacher, J Gertsch - Advances in biological regulation, 2021 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S2212492621000245 Quality of life and a surveillant endocannabinoid system RA de Melo Reis , AR Isaac, HR Freitas - Frontiers in , 2021 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fnins.2021.747229/full Hypotensive effects of hemopressin and bradykinin in rabbits, rats and mice: a comparative study PA Blais, J CacaÂŽte, J Morin, A Larouche, G Gendron - Peptides, 2005 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0196978105001476 DOES hemopressin bind metal ions in vivo? M Remelli , C Ceciliato, R Guerrini, P Kolkowska - Dalton , 2016 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2016/dt/c6dt03598a Peptidomic analysis of the neurolysin-knockout mouse brain LM Castro , DMLP Cavalcanti, CB Araujo , V Rioli - Journal of , 2014 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1874391914001651 Neurolysin Knockout Mice Generation and Initial Phenotype Characterization JC Rosa, MC leite Seelaender, RX Neves , V Oliveira - academia.eduhttps://www.academia.edu/download/57149052/Neurolysin_Knockout_Mice_Generation_and_20180807-5208-11akm1c.pdf Produaca§aca£o e purificaaca§aca£o do peptacaÂdeo hemopressina visando potencial farmacologico DM Oliveira - 2018 - realp.unb.brhttp://www.realp.unb.br/jspui/handle/10482/32579 MP-13, a novel chimeric peptide of morphiceptin and pepcan-9, produces potent antinociception with limited side effects C Mei, J Zhang, Z Niu, JP Simon, T Yang, M Huang - Neuropeptides, 2024 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0143417924000398 Hemopressin as a breakthrough for the cannabinoid field AS Heimann , CS Dale , FS Guimaraca£es , RAM Reis - , 2021 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0028390820304743 NFKF is a synthetic fragment derived from rat hemopressin that protects mice from neurodegeneration AS Heimann , AC Giardini, MB Sant'Anna - Neuroscience , 2020 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0304394020300355 New insights into peptide cannabinoids: structure, biosynthesis and signaling A Riquelme-Sandoval, CO de Sa-Ferreira - Frontiers in , 2020 - frontiersin.orghttps://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2020.596572DL-Homophenylalanine
CAS:Formula:C10H13NO2Purity:>97.0%(T)(HPLC)Color and Shape:White to Almost white powder to crystalMolecular weight:179.22Biotin-dPEG®11-Lipoamide
CAS:Biotin-dPEG®11-Lipoamide is a PEG compound with two different functional groups (also known as heterobifunctional). Unlike homobifunctional PEG compounds (same functional group on both ends), this type of compounds are more versatile as have two different anchor points. Biotin-dPEG®11-Lipoamide is used as a linker and spacer to add a PEG moiety, via pegylation (a bioconjugation technique) to proteins, peptides, oligonucleotides, small molecules and nanoparticles.Formula:C42H78N4O14SPurity:Min. 95%Molecular weight:959.28 g/molTumstatin (69-88)
Tumstatin is an anti-angiogenic matrikine fragment of collagen IV alpha3 subunit and a VEGF antagonist. Matrikines are bioactive extra cellular matrix (ECM) fragments which regulate cellular metabolism and influence ECM deposition and degradation. Airways of people with asthma have an 18-fold reduction in the levels tumstatin in their airway walls. Tumstatin reverses airway inflammation and remodelling in animal models of asthma in a mechanism involving autocrine remodelling of the ECM. The ECM regulates many aspects of cell biology including gene expression and inflammatory pathways. The airways ECM in asthma has been implicated in airway hyper-responsiveness (AHR), airway thickening, chronic inflammation and increased angiogenesis. Tumstatin fosters an anti-inflammatory and anti-angiogenic microenvironment which inhibits neutrophils in the airway tissue by modifying airway smooth muscle (ASM)-derived ECM. Tumstatin is present in endothelial cells, airway epithelial cells and primary lung fibroblasts, but not in primary ASM cells.Molecular weight:2,406.1 g/molFluor-PKYVKQNTLKLAT-OH
Peptide Fluor-PKYVKQNTLKLAT-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Fluor-PKYVKQNTLKLAT-OH include the following: Structural basis for the presentation of tumor-associated MHC class II-restricted phosphopeptides to CD4+ T cells Y Li, FR Depontieu, J Sidney , TM Salay - Journal of molecular , 2010 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0022283610004110 Differences in self-peptide binding between T1D-related susceptible and protective DR4 subtypes X Ge , EA James, H Reijonen, WW Kwok - Journal of autoimmunity, 2011 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0896841110001472 Peptide-induced immune regulation by a promiscuous and immunodominant CD4T-cell epitope of Timothy grass pollen: a role of Cbl-b and Itch in regulation SJ Till , EJ Raynsford, CJ Reynolds, KJ Quigley - Thorax, 2014 - thorax.bmj.comhttps://thorax.bmj.com/content/69/4/335.short Functional recombinant MHC class II molecules and high-throughput peptide-binding assays S Justesen, M Harndahl, K Lamberth, LLB Nielsen - Immunome , 2009 - Springerhttps://link.springer.com/article/10.1186/1745-7580-5-2 Changing ABRA protein peptide to fit into the HLA-DRbeta1* 0301 molecule renders it protection-inducing LM Salazar, MP Alba, H Curtidor , A Bermacaºdez - Biochemical and , 2004 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006291X04015803 MHC allele-specific binding of a malaria peptide makes it become promiscuous on fitting a glycine residue into pocket 6 LE Vargas , CA Parra, LM Salazar, F Guzman - Biochemical and , 2003 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006291X0301129X A novel method to measure HLA-DM-susceptibility of peptides bound to MHC class II molecules based on peptide binding competition assay and differential IC50 L Yin , LJ Stern - Journal of immunological methods, 2014 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0022175914000544 The ADAMTS131239-1253 peptide is a dominant HLA-DR1-restricted CD4+ T-cell epitope L Gilardin, S Delignat, I Peyron , M Ing, YC Lone - , 2017 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5664387/ A diverse set of oligomeric class II MHC-peptide complexes for probing T-cell receptor interactions JR Cochran, LJ Stern - Chemistry & Biology, 2000 - cell.comhttps://www.cell.com/cell-chemical-biology/pdf/S1074-5521(00)00019-3.pdf T-cell responses over time in a mild hemophilia A inhibitor subject: epitope identification and transient immunogenicity of the corresponding self-peptide EA James, WW Kwok, RA Ettinger - Journal of Thrombosis , 2007 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1538783622082770 Identification of HLA-DR4-restricted immunogenic peptide derived from xenogenic porcine major histocompatibility complex class I molecule CS Park, KH Kim, SA Im, S Song - Xenotransplantation, 2012 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/xen.12001 Enhanced detection of antigen-specific CD4+ T cells using altered peptide flanking residue peptide-MHC class II multimers CJ Holland, G Dolton , M Scurr , K Ladell - The Journal of , 2015 - journals.aai.orghttps://journals.aai.org/jimmunol/article/195/12/5827/108954 Design and synthesis of a competent pyrrolinone-peptide hybrid ligand for the class II major histocompatibility complex protein HLA-DR1 AB Smith, AB Benowitz , PA Sprengeler - Journal of the , 1999 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/ja991251eH-STTTGHLIYK-OH
Peptide H-STTTGHLIYK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-STTTGHLIYK-OH include the following: Methylation of translation-associated proteins in Saccharomyces cerevisiae: Identification of methylated lysines and their methyltransferases TA Couttas , MJ Raftery, MP Padula , BR Herbert - , 2012 - Wiley Online Libraryhttps://analyticalsciencejournals.onlinelibrary.wiley.com/doi/abs/10.1002/pmic.201100570 Analysis of protein methylation in the Saccharomyces cerevisiae cell-cycle SZ Chia - 2011 - unsworks.unsw.edu.auhttps://unsworks.unsw.edu.au/entities/publication/e6ecfdae-f116-4c42-8cea-d1313efd8a48 A new type of protein lysine methyltransferase trimethylates Lys-79 of elongation factor 1A MC Dzialo, KJ Travaglini , S Shen, JA Loo - and biophysical research , 2014 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006291X14020324H-TQLNRALTGIAVEQD-OH
Peptide H-TQLNRALTGIAVEQD-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-TQLNRALTGIAVEQD-OH include the following: Structural definition of HLA class II-presented SARS-CoV-2 epitopes reveals a mechanism to escape pre-existing CD4+ T cell immunity Y Chen, GH Mason, DO Scourfield - Cell Reports, 2023 - cell.comhttps://www.cell.com/cell-reports/pdf/S2211-1247(23)00838-0.pdfAc-RDGY-NH2
Peptide Ac-RDGY-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Ac-RDGY-NH2 include the following: Electropolymerized tyrosine-based thin films: Selective cell binding via peptide recognition to novel electropolymerized biomimetic tyrosine RGDY films KA Marx , T Zhou, D McIntosh, SJ Braunhut - Analytical biochemistry, 2009 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0003269708006404L-Aspartic acid, N-[(phenylmethoxy)carbonyl]-, 1-methyl ester
CAS:Formula:C13H15NO6Purity:98%Color and Shape:SolidMolecular weight:281.2613H-YTIAALLSPYSYSTTAVVTNPK^-OH
Peptide H-YTIAALLSPYSYSTTAVVTNPK^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-YTIAALLSPYSYSTTAVVTNPK^-OH include the following: Die Bedeutung von Transthyretin und HSP 27 in der alternden Epidermis JA Kieslich - 2005 - ediss.sub.uni-hamburg.dehttps://ediss.sub.uni-hamburg.de/handle/ediss/1224HXB2 gag NO-29
Custom research peptide; min purity 95%. For different specs please use the Peptide Quote ToolMolecular weight:1,554.6 g/molAPP Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of APP antibody, catalog no. 70R-6196Purity:Min. 95%MSI2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of MSI2 antibody, catalog no. 70R-1394Purity:Min. 95%LL-37, Antimicrobial Peptide, human
Catalogue peptide; min. 95% purityFormula:C205H340N60O53Molecular weight:4,493.37 g/molH-NPATTNQTEFER-OH
Peptide H-NPATTNQTEFER-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-NPATTNQTEFER-OH include the following: A peptide-centric local stability assay to unveil protein targets of diverse ligands K Li, S Chen, K Wang, Y Wang, Z Fang, J Lyu, H Zhu - bioRxiv, 2023 - biorxiv.orghttps://www.biorxiv.org/content/10.1101/2023.10.17.562693.abstractNH2-MPIGSKERPTFFEIFC-NH2 Acetate salt
Please enquire for more information about NH2-MPIGSKERPTFFEIFC-NH2 Acetate salt including the price, delivery time and more detailed product information at the technical inquiry form on this pageGPT Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of GPT antibody, catalog no. 70R-1193Purity:Min. 95%POLE4 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of POLE4 antibody, catalog no. 70R-8343Purity:Min. 95%H-LSEAEFEVLK-OH
Peptide H-LSEAEFEVLK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-LSEAEFEVLK-OH include the following: Characterization of coagulation factor synthesis in nine human primary cell types M Dashty, V Akbarkhanzadeh, CJ Zeebregts - Scientific reports, 2012 - nature.comhttps://www.nature.com/articles/srep00787Leu-Pro-Leu-Arg-Phe-NH2 diacetate dihydrate
Please enquire for more information about Leu-Pro-Leu-Arg-Phe-NH2 diacetate dihydrate including the price, delivery time and more detailed product information at the technical inquiry form on this pageFormula:C32H53N9O5•2CH3COOH•2H2OPurity:Min. 95%Molecular weight:799.96 g/molN-Hippuryl-His-Leu trifluroacetate hydrate
CAS:Please enquire for more information about N-Hippuryl-His-Leu trifluroacetate hydrate including the price, delivery time and more detailed product information at the technical inquiry form on this pageFormula:C21H27N5O5(C2F3O2)x(H2O)xPurity:Min. 95%Molecular weight:429.47 g/molNET1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of NET1 antibody, catalog no. 70R-3139Purity:Min. 95%CDC2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CDC2 antibody, catalog no. 70R-5614Purity:Min. 95%H-IP^AMVVDR-OH
Peptide H-IP^AMVVDR-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-IP^AMVVDR-OH include the following: LC-MS/MS multiplexed assay for the quantitation of a therapeutic protein BMS-986089 and the target protein Myostatin Y Zhu, C D'Arienzo, Z Lou, A Kozhich, M Madireddi - Bioanalysis, 2016 - Future Sciencehttps://www.future-science.com/doi/abs/10.4155/bio.15.238 A multiplexed immunocapture liquid chromatography tandem mass spectrometry assay for the simultaneous measurement of myostatin and GDF-11 in rat serum using Y Zhao, G Liu, FC Zambito, YJ Zhang, BS DeSilva - Analytica chimica , 2017 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0003267017305007 ORAL O11 HEADACHE WITH ANALYSIS OF NSAIDS IN FOODS OF ANIMAL ORIGIN P Jedziniak , K Pietruk - RESIDUES OF VETERINARY DRUGS IN FOOD, 2022 - vliz.behttps://www.vliz.be/imisdocs/publications/390419.pdf#page=66 Age trends in growth and differentiation factor-11 and myostatin levels in healthy men, and differential response to testosterone, measured using liquid L Peng, T Gagliano-Juca , KM Pencina - The Journals of , 2022 - academic.oup.comhttps://academic.oup.com/biomedgerontology/article-abstract/77/4/763/6284042 Targeted approach to distinguish and determine absolute levels of GDF8 and GDF11 in mouse serum L Camparini, L Kollipara , G Sinagra, FS Loffredo - , 2020 - Wiley Online Libraryhttps://analyticalsciencejournals.onlinelibrary.wiley.com/doi/abs/10.1002/pmic.201900104 Dystrophin-deficient dogs with reduced myostatin have unequal muscle growth and greater joint contractures JN Kornegay , DJ Bogan, JR Bogan, JL Dow, J Wang - Skeletal muscle, 2016 - Springerhttps://link.springer.com/article/10.1186/s13395-016-0085-7 Quantitative measurements of GDF-8 using immunoaffinity LC-MS/MS J Palandra, A Quazi, L Fitz , H Rong - PROTEOMICS , 2016 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/prca.201500112 A sensitive antibody-free 2D-LC-MS/MS assay for the quantitation of myostatin in the serum of different species G Zhang, S Chen, K Song, P Pan, Y Qiu , L Amaravadi - Bioanalysis, 2019 - Future Sciencehttps://www.future-science.com/doi/abs/10.4155/bio-2018-03115-Hydroxy-L-tryptophan
CAS:Formula:C11H12N2O3Purity:>98.0%(T)(HPLC)Color and Shape:White to Light yellow powder to crystalMolecular weight:220.23H-Gly-Pro-Arg-Pro-OH
CAS:Controlled ProductH-Gly-Pro-Arg-Pro-OH is a sealant that has been shown to be effective in the treatment of bowel disease. It is a calcium binding compound that can be administered topically or systemically. H-Gly-Pro-Arg-Pro-OH has clinical relevance in vivo with human beings and exhibits ATP levels that are similar to those found in normal tissue. The surface glycoprotein of this compound has been shown to have an affinity for epidermal growth factor, which may play a role in inflammatory bowel disease. HGPAROH is activated by fibrinogen, which leads to its bound form being recognized by monoclonal antibody as well as the human serum proteins (e.g., albumin).Formula:C18H31N7O5Purity:Min. 95%Molecular weight:425.48 g/molIL4 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of IL4 antibody, catalog no. 70R-6232Purity:Min. 95%ZNF428 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF428 antibody, catalog no. 70R-7870Purity:Min. 95%H-AAAAAAA-OH
Peptide H-AAAAAAA-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-AAAAAAA-OH include the following: Early endosomal escape of a cyclic cell-penetrating peptide allows effective cytosolic cargo delivery Z Qian , JR LaRochelle, B Jiang , W Lian, RL Hard - Biochemistry, 2014 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/bi5004102 The use of chromium (III) complexes to enhance peptide protonation by electrospray ionization mass spectrometry X Jing, KC Edwards, JB Vincent - Journal of mass , 2018 - Wiley Online Libraryhttps://analyticalsciencejournals.onlinelibrary.wiley.com/doi/abs/10.1002/jms.4297 On-demand self-assembling peptide amphiphiles for cancer V DEL GENIO , A Falanga, L Lombardi - Imaging of diagnostic , 2019 - iris.unina.ithttps://www.iris.unina.it/handle/11588/770118 Asaki Kagoshima, Kanako Sekimoto & M Takayama - J. Am. Soc. Mass Spectrom, 2019 - researchmap.jphttps://researchmap.jp/read0074226/published_papers/22377641/attachment_file.pdf Solid Phase Peptide Synthesis of Same Amino Acid Based Sequence M Halim, A Mokhtari - 2023 - digitalcommons.kennesaw.eduhttps://digitalcommons.kennesaw.edu/undergradsymposiumksu/spring2023/presentations/222/ Replica exchange molecular dynamics simulations of amyloid peptide aggregation M Cecchini , F Rao , M Seeber , A Caflisch - The Journal of chemical , 2004 - pubs.aip.orghttps://pubs.aip.org/aip/jcp/article-abstract/121/21/10748/595698 Enhancing the potency of antimicrobial peptides through molecular engineering and self-assembly L Lombardi , Y Shi , A Falanga, E Galdiero - , 2019 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.biomac.8b01740 Optimization of electrospray ionization conditions to enhance formation of doubly protonated peptide ions with and without addition of chromium (III) JJ Commodore, X Jing - Rapid Communications in , 2017 - Wiley Online Libraryhttps://analyticalsciencejournals.onlinelibrary.wiley.com/doi/abs/10.1002/rcm.7889 Study on the self-assembly of aromatic antimicrobial peptides based on different PAF26 peptide sequences F Cao, G Zhu, M Song, X Zhao, G Ma, M Zhang - e-Polymers, 2022 - degruyter.comhttps://www.degruyter.com/document/doi/10.1515/epoly-2022-0012/html A comparison of positive and negative ion collision-induced dissociation for model heptapeptides with one basic residue D Pu, NL Clipston, CJ Cassady - Journal of mass spectrometry, 2010 - Wiley Online Libraryhttps://analyticalsciencejournals.onlinelibrary.wiley.com/doi/abs/10.1002/jms.1715 Intramolecular Hydrogen Transfer from the Alpha-Carbon (Calpha) and Backbone Amide Nitrogen (Nb) to Form c- and y-Ions in Negative-Ion CID of Peptides A Kagoshima, K Sekimoto , M Takayama - Journal of The American , 2019 - Springerhttps://link.springer.com/article/10.1007/s13361-019-02245-z Development of Amphiphilic Short Peptides to Control Drug Inclusivity through Metal Complexation Reactions A Inada, M Hitotsumatsu, T Oshima - Journal of Chemical , 2023 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/00219592.2023.2219291H-FLNQTDETL^-OH
Peptide H-FLNQTDETL^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-FLNQTDETL^-OH include the following: Definition of the T Cell-Mediated Immune Response to Mammaglobin, a Novel Breast Cancer-Associated Protein T Mohanakumar, WASHINGTON UNIV ST LOUIS MO - 2000 - apps.dtic.milhttps://apps.dtic.mil/sti/citations/tr/ADA410575[Nle12] a-factor
[Nle12] alpha-factor is a cyclic analog of the Saccharomyces cerevisiae alpha-factor mating pheromone.Molecular weight:1,663.9 g/molNH2-dPEG®4-Glu(OH)-NH-dPEG®4-Glu(OH)-NH-m-dPEG®24
NH2-dPEG®4-Glu(OH)-NH-dPEG®4-Glu(OH)-NH-m-dPEG®24 is a peptide containing polyethylene glycol (PEG) as spacer to alter their pharmacokinetic properties and pharmodynamics.Formula:C97H185N7O48Purity:Min. 95%Molecular weight:2,217.52 g/molH-LTILDQSEAPVR^-OH
Peptide H-LTILDQSEAPVR^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-LTILDQSEAPVR^-OH include the following: Key Roles of Ubiquitination and Phosphorylation in RIG-I/MAVS Viral Sensing Pathway S Liu - 2013 - utswmed-ir.tdl.orghttps://utswmed-ir.tdl.org/items/f448f63f-dea7-44b7-a0e6-f31e92fe9d06Plasminogen Light Tryptic Peptide Standard (4nmol)
For Protein Identification and QuantitationPurity:Min. 95%H-YFPLQSYGFQPTNGVGYQPYRVVVL-OH
Peptide H-YFPLQSYGFQPTNGVGYQPYRVVVL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-YFPLQSYGFQPTNGVGYQPYRVVVL-OH include the following: SARS-CoV-2 spike protein-derived immunogenic peptides that are promiscuously presented by several HLA-class II molecules and their potential for inducing Y Yajima, A Kosaka, T Ohkuri, Y Hirohashi , D Li - Heliyon, 2023 - cell.comhttps://www.cell.com/heliyon/pdf/S2405-8440(23)07400-5.pdfArginase 1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ARG1 antibody, catalog no. 70R-1085Purity:Min. 95%Slc22a3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of Slc22a3 antibody, catalog no. 70R-8591Purity:Min. 95%Nε-Trifluoroacetyl-L-lysine
CAS:Formula:C8H13F3N2O3Purity:>98.0%(T)(HPLC)Color and Shape:White to Almost white powder to crystalMolecular weight:242.20SERPINE1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SERPINE1 antibody, catalog no. 70R-5413Purity:Min. 95%Annexin A13 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ANXA13 antibody, catalog no. 70R-1674Purity:Min. 95%CREBtide
CAS:Custom research peptide; min purity 95%. For different specs please use the Peptide Quote ToolFormula:C73H129N29O19Molecular weight:1,717 g/molPeroxiredoxin 3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of Adam22 antibody, catalog no. 70R-8650Purity:Min. 95%Z-Arg-Leu-Arg-Gly-Gly-AMC acetate
CAS:Z-Arg-Leu-Arg-Gly-Gly-AMC acetate is a protease inhibitor that blocks the activity of the proteasome. It has been shown to inhibit the activity of histidine proteases and to inhibit proteolysis by the proteasome in a kinetic assay. This inhibitor also inhibits coronavirus replication, which may be due to its ability to bind to histidine residues on proteins involved in viral replication. Z-Arg-Leu-Arg-Gly-Gly-AMC acetate is expressed in transfected cells as an enzyme with a polymerase chain reaction (PCR) product and has been shown to prevent viral replication.Formula:C40H56N12O9•(C2H4O2)xPurity:Min. 98 Area-%Color and Shape:PowderMolecular weight:848.95 g/molAmino-dPEG®8-OH
CAS:Amino-dPEG®8-OH is a PEG polymer categorised as monofunctional (OH-PEG-X). Used as a linker, amino-dPEG®8-OH is used to attached PEG to proteins, peptides, oligonucleotides, nanoparticles and small molecules via pegylation, a bioconjugation technique.Formula:C16H35NO8Purity:Min. 95%Molecular weight:369.45 g/molKCNA10 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of KCNA10 antibody, catalog no. 70R-1497Purity:Min. 95%H-HP-OH
Peptide H-HP-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-HP-OH include the following: Design and characterization of novel hybrid peptides from LFB15 (W4, 10), HP (2-20), and cecropin A based on structure parameters by computer-aided method Z Tian, T Dong, D Teng, Y Yang, J Wang - Applied microbiology and , 2009 - Springerhttps://link.springer.com/article/10.1007/s00253-008-1839-x Design of novel analogues with potent antibiotic activity based on the antimicrobial peptide, HP (2-9)-ME (1-12) Y Park, HN Kim, SN Park, SH Jang, CH Choi - Biotechnology , 2004 - Springerhttps://link.springer.com/article/10.1023/B:BILE.0000019556.79703.4b Synthesis of beta-1 and beta-2-adamantylaspartates and their evaluation for peptide synthesis Y Okada, S Iguchi, K Kawasaki - Journal of the Chemical Society , 1987 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/1987/c3/c39870001532 Effect of Glycosylation on Cis/Trans Isomerization of Prolines in IgA1-Hinge Peptide Y Narimatsu , T Kubota , S Furukawa - Journal of the , 2010 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/ja9106429 Helical structure motifs made searchable for functional peptide design TY Kuo, L Voon, A Sharma , KD Hu, YY Cheng10 - academia.eduhttps://www.academia.edu/download/104047688/s41467-021-27655-0.pdf Antinematodal activity and the mechanism of the antimicrobial peptide, HP (2-20), against Caenorhabditis elegans SH Jang , Y Park, SC Park, P Il Kim, DG Lee - Biotechnology , 2004 - Springerhttps://link.springer.com/article/10.1023/B:BILE.0000015427.26410.d4 Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions SC Park, MH Kim, MA Hossain, SY Shin, Y Kim - et Biophysica Acta (BBA , 2008 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0005273607003811 A peptide sequence of heparin/heparan sulfate (HP/HS)-interacting protein supports selective, high affinity binding of HP/HS and cell attachment S Liu, JA Julian, DD Carson - Journal of Biological Chemistry, 1998 - ASBMBhttps://www.jbc.org/article/S0021-9258(18)46190-X/abstract The effects of peptides on the stimulus properties of ethanol RE Chipkin, JM Stewart, K Channabasavaiah - Biochemistry and Behavior, 1980 - Elsevierhttps://www.sciencedirect.com/science/article/pii/0091305780904219 Synthesis and NMR spectroscopy of peptides containing either phosphorylated or phosphonylated cis- or trans-4-hydroxy-L-proline R HOFFMAN , T HOFFMAN, A Tholey - Journal of peptide , 1997 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1399-3011.1997.tb00611.x Prevention of lethal murine candidiasis using HP (2-20), an antimicrobial peptide derived from the N-terminus of Helicobacter pylori ribosomal protein L1 PD Ribeiro, E Medina-Acosta - Peptides, 2003 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0196978103003565 Syntheses of C-peptides and human proinsulin N Yanaihara, C Yanaihara, M Sakagami, N Sakura - Diabetes, 1978 - Am Diabetes Assochttps://diabetesjournals.org/diabetes/article/27/Supplement_1/149/4923 The role played by lipids unsaturation upon the membrane interaction of the Helicobacter pylori HP (2-20) antimicrobial peptide analogue HPA3 L Mereuta , T Luchian , Y Park, KS Hahm - Journal of bioenergetics and , 2009 - Springerhttps://link.springer.com/article/10.1007/s10863-009-9204-z Interactions between the plasma membrane and the antimicrobial peptide HP (2-20) and its analogues derived from Helicobacter pylori KH Lee, DG Lee, Y Park, DI Kang, SY Shin - Biochemical , 2006 - portlandpress.comhttps://portlandpress.com/biochemj/article-abstract/394/1/105/42129 Preparation, characterization, and property evaluation of Hericium erinaceus peptide-calcium chelate H Gu, L Liang, Y Kang, R Yu, J Wang, D Fan - Frontiers in Nutrition, 2024 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fnut.2023.1337407/full Peptide aldehyde inhibitors of the kallikreins: an investigation of subsite interactions with tripeptides containing structural variations at the amino terminus GS Garrett, PE Correa, SJ McPhail - Journal of peptide , 1998 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1399-3011.1998.tb00653.x A mechanistic investigation of the enhanced cleavage at histidine in the gas-phase dissociation of protonated peptides G Tsaprailis, H Nair, W Zhong , K Kuppannan - Analytical , 2004 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/ac034971j Identification of novel antihypertensive peptides from wine lees hydrolysate FI Bravo , A Mas-Capdevila - Food Chemistry, 2022 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0308814621016964 Influence on the plasma membrane of Candida albicans by HP (2-9)-magainin 2 (1-12) hybrid peptide DG Lee, Y Park, PI Kim , HG Jeong , ER Woo - Biochemical and , 2002 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006291X02022301 Antifungal mechanism of an antimicrobial peptide, HP (2-20), derived from N-terminus of Helicobacter pylori ribosomal protein L1 against Candida albicans DG Lee, Y Park, HN Kim , HK Kim, PI Kim - Biochemical and , 2002 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006291X02965484 HP (2-20) derived from the amino terminal region of Helicobacter pylori ribosomal protein L1 exerts its antifungal effects by damaging the plasma membranes of DG Lee, PI Kim , Y Park, SH Jang - Journal of Peptide , 2002 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/psc.405 Design of novel analogue peptides with potent antibiotic activity based on the antimicrobial peptide, HP (2-20), derived from N-terminus of Helicobacter pylori DG Lee, HN Kim , Y Park, HK Kim, BH Choi - et Biophysica Acta (BBA , 2002 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0167483802003734 Peptide Hp (2-20) accelerates healing of TNBS-induced colitis in the rat AG Gravina, N Prevete, C Tuccillo - United European , 2018 - journals.sagepub.comhttps://journals.sagepub.com/doi/abs/10.1177/2050640618793564Lipocalin 1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of LCN1 antibody, catalog no. 70R-5914Purity:Min. 95%Antihypertensive peptide ITTNP
Custom research peptide; min purity 95%. For different specs please use the Peptide Quote ToolFormula:C23H40N6O9Molecular weight:544.6 g/molH-GTITSGWTF-OH
Peptide H-GTITSGWTF-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-GTITSGWTF-OH include the following: Patricio Oyarzun 1*, Manju Kashyap1, Victor Fica1, Alexis Salas-Burgos2, Faviel F. Gonzalez-Galarza3, Antony McCabe4, Andrew R. Jones4, Derek Middleton4 and K Ewer , JA Padilla, SR Bonam - Development of Vaccines ..., 2022 - books.google.comhttps://books.google.com/books?hl=en&lr=&id=xcZaEAAAQBAJ&oi=fnd&pg=PA186&dq=(%22H-Gly-Thr-Ile-Thr-Ser-Gly-Trp-Thr-Phe-acid%22+OR+%22H-GTITSGWTF-OH%22+OR+%22GTITSGWTF%22+OR+%22Gly-Thr-Ile-Thr-Ser-Gly-Trp-Thr-Phe%22)+AND+peptide&ots=lRZ41J3bIC&sig=CoNmRuBuvyHM7dlYgeDMTd-bo3o A proteome-wide immunoinformatics tool to accelerate T-cell epitope discovery and vaccine design in the context of emerging infectious diseases: an ethnicity P Oyarzun , M Kashyap, V Fica, A Salas-Burgos - Frontiers in ..., 2021 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2021.598778/fullAYPGKF-NH2
CAS:Peptide AYPGKF-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using AYPGKF-NH2 include the following: Protease-activated receptor 4 activation increases the expression of calcitonin gene-related peptide mRNA and protein in dorsal root ganglion neurons Z Wang, D Chen, Z Zhang, R Zhang - Journal of , 2013 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/jnr.23280 Development of novel inhibitors of thrombosis for the prevention of cardiovascular events S Wilson - 2021 - era.ed.ac.ukhttps://era.ed.ac.uk/handle/1842/38363 PAR-4 agonist AYPGKF stimulates thromboxane production by human platelets RA Henriksen, VK Hanks - Arteriosclerosis, thrombosis, and , 2002 - Am Heart Assochttps://www.ahajournals.org/doi/abs/10.1161/01.ATV.0000014742.56572.25 Protease-activated receptor 4: a critical participator in inflammatory response Q Fu, J Cheng, Y Gao, Y Zhang, X Chen, J Xie - Inflammation, 2015 - Springerhttps://link.springer.com/article/10.1007/s10753-014-9999-6 Molecular Mechanisms Regulating the Platelet Thrombin Receptor PAR4 PE Thibeault - 2020 - search.proquest.comhttps://search.proquest.com/openview/917facff59ec416fb10dada33ba87e1c/1?pq-origsite=gscholar&cbl=18750&diss=y Insights into Proteinase Activated Receptor 4 (PAR4) signaling, trafficking and biased agonism P Thibeault, JC Lesarge, M Fernandes - for Annual Meeting of , 2018 - jstage.jst.go.jphttps://www.jstage.jst.go.jp/article/jpssuppl/WCP2018/0/WCP2018_OR10-2/_article/-char/ja/ Characterization of thrombin-induced leukocyte rolling and adherence: a potential proinflammatory role for proteinase-activated receptor-4 N Vergnolle , CK Derian, MR D'Andrea - The Journal of , 2002 - journals.aai.orghttps://journals.aai.org/jimmunol/article/169/3/1467/34921 Proteinase-activated receptor-1 (PAR-1) activation contracts the isolated human renal artery in vitro M Tognetto, MR D'Andrea, M Trevisani - British journal of , 2003 - Wiley Online Libraryhttps://bpspubs.onlinelibrary.wiley.com/doi/abs/10.1038/sj.bjp.0705215 Activation of proteinase-activated receptors induces itch-associated response through histamine-dependent and-independent pathways in mice K Tsujii, T Andoh , JB Lee, Y Kuraishi - Journal of pharmacological sciences, 2008 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1347861319313477 Biological activity of Helicobacter pylori components in mammalian cells: is it independent of proteinase-activated receptors F Sekiguchi , Y Matsumoto, Y Maeda - J Physiol , 2012 - jpp.krakow.plhttps://www.jpp.krakow.pl/journal/archive/12_12/pdf/571_12_12_article.pdf Protease-activated receptors (PARs) as therapeutic targets: development of agonists/antagonists and modulation of gastrointestinal functions F Sekiguchi , A Kawabata - Drug Design Reviews-Online , 2004 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/ddro/2004/00000001/00000004/art00002 P. Faria-Pinto, MTP Lopes & Andre Klein A Barra, KM Freitas, DG Marconato - researchgate.nethttps://www.researchgate.net/profile/Andre-Klein-7/publication/345507782_Naunyn-Schmiedeberg's_Archives_of_Pharmacology_Protease-activated_receptor_4_plays_a_role_in_lipopolysaccharide-induced_inflammatory_mechanisms_in_murine_macrophages_Protease-activated_receptor_4_play/links/5fa85422a6fdcc0624200b34/Naunyn-Schmiedebergs-Archives-of-Pharmacology-Protease-activated-receptor-4-plays-a-role-in-lipopolysaccharide-induced-inflammatory-mechanisms-in-murine-macrophages-Protease-activated-receptor-4-plays.pdfFormula:C34H48N8O7Molecular weight:680.79 g/molMCM10 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of MCM10 antibody, catalog no. 70R-5512Purity:Min. 95%H-EPDVYYTSAFVFPTK-OH
Peptide H-EPDVYYTSAFVFPTK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-EPDVYYTSAFVFPTK-OH include the following: Toll-like receptor 7/8-matured RNA-transduced dendritic cells as post-remission therapy in acute myeloid leukaemia: results of a phase I trial FS Lichtenegger, FM Schnorfeil - Clinical & , 2020 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/cti2.1117 Lost in translation: lack of CD4 expression due to a novel genetic defect A Lisco , P Ye, CS Wong, L Pei , AP Hsu - The Journal of , 2021 - academic.oup.comhttps://academic.oup.com/jid/article-abstract/223/4/645/6104628Butanamide, 2-amino-4-(methylthio)-, hydrochloride (1:1), (2S)-
CAS:Formula:C5H13ClN2OSPurity:98%Color and Shape:SolidMolecular weight:184.6875H-NSLANPGIA-OH
Peptide H-NSLANPGIA-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-NSLANPGIA-OH include the following: Immunosuppression overcomes insulin-and vector-specific immune responses that limit efficacy of AAV2/8-mediated insulin gene therapy in NOD mice NJ Holmes - 2018 - repository.cam.ac.ukhttps://www.repository.cam.ac.uk/items/96c9ef9a-eb7f-439d-b64d-e82cacc1abc3 IL12-mediated liver inflammation reduces the formation of AAV transcriptionally active forms but has no effect over preexisting AAV transgene expression I Gil-Fariaca±a, M Di Scala, L Vanrell, C Olague, A Vales - PLoS , 2013 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0067748 Identification of mouse AAV capsid-specific CD8+ T cell epitopes DE Sabatino, F Mingozzi, DJ Hui, H Chen, P Colosi - Molecular Therapy, 2005 - cell.comhttps://www.cell.com/molecular-therapy-family/molecular-therapy/fulltext/S1525-0016(05)01606-0 Immunosuppression overcomes insulin-and vector-specific immune responses that limit efficacy of AAV2/8-mediated insulin gene therapy in NOD mice A Recino, SU Gan , KC Sia , Y Sawyer, J Trendell - Gene Therapy, 2019 - nature.comhttps://www.nature.com/articles/s41434-018-0052-5DRAM Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of DRAM antibody, catalog no. 70R-9619Purity:Min. 95%RALGPS2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of RALGPS2 antibody, catalog no. 70R-2184Purity:Min. 95%H-LDETVVNR-OH
Peptide H-LDETVVNR-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-LDETVVNR-OH include the following: Commercially available antibodies can be applied in quantitative multiplexed peptide immunoaffinity enrichment targeted mass spectrometry assays RM Schoenherr, L Zhao, RG Ivey, UJ Voytovich - , 2016 - Wiley Online Libraryhttps://analyticalsciencejournals.onlinelibrary.wiley.com/doi/abs/10.1002/pmic.201500540ZNF524 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF524 antibody, catalog no. 70R-8443Purity:Min. 95%ZNF417 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF417 antibody, catalog no. 70R-8133Purity:Min. 95%H-VHGLEIQGR^-OH
Peptide H-VHGLEIQGR^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-VHGLEIQGR^-OH include the following: Mitochondrial amidoxime-reducing component 1 p. Ala165Thr increases protein degradation mediated by the proteasome T Dutta , K Sasidharan , E Ciociola, G Pennisi - Liver , 2024 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/liv.15857H-QPRLTPPQPL-OH
Peptide H-QPRLTPPQPL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-QPRLTPPQPL-OH include the following: Early T cell recognition of B cells following Epstein-Barr virus infection: identifying potential targets for prophylactic vaccination JM Brooks , HM Long , RJ Tierney- PLoS ..., 2016 - journals.plos.orghttps://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1005549H-CYTWNQMNL-OH
Peptide H-CYTWNQMNL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-CYTWNQMNL-OH include the following: WT1 peptide vaccine induces reduction in minimal residual disease in an Imatinib-treated CML patient Y Oji, Y Oka, S Nishida, A Tsuboi - European journal of , 2010 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1600-0609.2010.01497.x Association of WT1 IgG antibody against WT1 peptide with prolonged survival in glioblastoma multiforme patients vaccinated with WT1 peptide Y Oji, N Hashimoto, A Tsuboi - journal of cancer, 2016 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.30182 WT1 peptide immunotherapy for cancer in children and young adults Y Hashii, E Sato, H Ohta, Y Oka - Pediatric blood & , 2010 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/pbc.22522 A Unique Immunotherapeutic Atrategy by Using a Leukemic Plasmacytoid Dendritic Cell Line (PMDC05) as Potent Antigen Presenting Cells. T Nakamura, M Narita, A Yamahira, N Watanabe - Blood, 2009 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006497119579174 Pilot study of WT1 peptide"âpulsed dendritic cell vaccination with docetaxel in esophageal cancer T Matsuda, H Takeuchi, T Sakurai - Oncology , 2018 - spandidos-publications.comhttps://www.spandidos-publications.com/10.3892/ol.2018.8734?text=fulltext Maintenance of complete remission after allogeneic stem cell transplantation in leukemia patients treated with Wilms tumor 1 peptide vaccine T Maeda, N Hosen, K Fukushima , A Tsuboi - Blood cancer , 2013 - nature.comhttps://www.nature.com/articles/bcj201329 Peptide vaccines for myeloid leukaemias T Dao, DA Scheinberg - Best Practice & Research Clinical Haematology, 2008 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1521692608000510 Wilms' tumor 1 (WT1) peptide immunotherapy for gynecological malignancy S Ohno , S Kyo, S Myojo, S Dohi, J Ishizaki - Anticancer , 2009 - ar.iiarjournals.orghttps://ar.iiarjournals.org/content/29/11/4779.short Phase I pilot study of Wilms tumor gene 1 peptide-pulsed dendritic cell vaccination combined with gemcitabine in pancreatic cancer S Mayanagi, M Kitago, T Sakurai, T Matsuda - Cancer , 2015 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/cas.12621 Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiforme S Izumoto, A Tsuboi, Y Oka, T Suzuki, T Hashiba - Journal of , 2008 - thejns.orghttps://thejns.org/view/journals/j-neurosurg/108/5/article-p963.xml Clinical peptide vaccination trials for leukemia patients R Casalegno-Garduno, A Schmitt - Expert Review of , 2011 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1586/erv.11.56 Long-term molecular remission with an increase of WT1-specific CTLs after cessation of WT1 peptide vaccination in a patient with CML M Takahashi - Annals of Oncology, 2015 - annalsofoncology.orghttps://www.annalsofoncology.org/article/S0923-7534(20)30762-6/fulltext Efficient Generation of HLA-A24-Restricted WT1-Specific Cytotoxic T Lymphocytes Using Gene-Engineered Artificial Antigen-Presenting Cells M Ogasawara, T Yamakawa, Y Katsura, K Shima - Blood, 2010 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006497119441682 New Peptide-Based Cancer Vaccine: Phase I and Early Phase II Clinical Trials for Castration-Resistant Prostate Cancer M Noguchi, S Suekane, F Moriya, T Sasada - Annals of , 2012 - annalsofoncology.orghttps://www.annalsofoncology.org/article/S0923-7534(20)32150-5/abstract Vaccination with WT-1 (Wilms' tumor gene-1) peptide and BCG-CWS in melanoma M Nishioka, A Tanemura, S Nishida, A Nakano - European Journal of , 2012 - jle.comhttps://www.jle.com/en/revues/ejd/e-docs/vaccination_with_wt_1_wilms_tumor_gene_1_peptide_and_bcg_cws_in_melanoma_292373/article.phtml The feasibility and clinical effects of dendritic cell-based immunotherapy targeting synthesized peptides for recurrent ovarian cancer M Kobayashi, A Chiba, H Izawa, E Yanagida - Journal of ovarian , 2014 - Springerhttps://link.springer.com/article/10.1186/1757-2215-7-48 Phase 1 trial of Wilms tumor 1 (WT1) peptide vaccine and gemcitabine combination therapy in patients with advanced pancreatic or biliary tract cancer M Kaida, Y Morita-Hoshi, A Soeda - Journal of , 2011 - journals.lww.comhttps://journals.lww.com/immunotherapy-journal/fulltext/2011/01000/phase_1_trial_of_wilms_tumor_1__wt1__peptide.9.aspx Peptide-based materials for cancer immunotherapy L Zhang, Y Huang , AR Lindstrom, TY Lin, KS Lam - Theranostics, 2019 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831480/ Establishment of a stable T lymphoma cell line transduced with HLA-AâËâ 24: 02-restricted WT1-specific TCR genes and its application to antigen-specific K Watanabe, S Toji, J Ohtake, K Nakano - Biomedical , 2013 - jstage.jst.go.jphttps://www.jstage.jst.go.jp/article/biomedres/34/1/34_41/_article/-char/ja/ WT1 (WILM'S TUMOR GENE) PEPTIDE CANCER VACCINE H Sugiyama - RECENT ADVANCES IN CANCER IMMUNOTHERAPY - ptcrf.or.jphttps://www.ptcrf.or.jp/academic/file/extended_abstract/2014_45extended_abstracts.pdf#page=100 WT1 Peptide-Based Cancer Immunotherapy H Sugiyama - Annals of Oncology, 2012 - annalsofoncology.orghttps://www.annalsofoncology.org/article/S0923-7534(20)32149-9/abstract Enhanced induction of human WT1-specific cytotoxic T lymphocytes with a 9-mer WT1 peptide modified at HLA-A* 2402-binding residues A Tsuboi, Y Oka, K Udaka, M Murakami - Cancer Immunology , 2002 - Springerhttps://link.springer.com/article/10.1007/s00262-002-0328-9 Wilms tumor gene WT1 peptide-based immunotherapy induced a minimal response in a patient with advanced therapy-resistant multiple myeloma A Tsuboi, Y Oka, H Nakajima, Y Fukuda - International journal of , 2007 - Springerhttps://link.springer.com/article/10.1007/bf02983998 Long-term administration of Wilms tumor-1 peptide vaccine in combination with gemcitabine causes severe local skin inflammation at injection sites A Soeda, Y Morita-Hoshi, M Kaida - Japanese journal of , 2010 - academic.oup.comhttps://academic.oup.com/jjco/article-abstract/40/12/1184/1820992 Gemcitabine/WT1 peptide loaded dendritic cell vaccine A Soeda - Reactions, 2011 - Springerhttps://link.springer.com/article/10.2165/00128415-201113350-00080 Feasibility of cancer immunotherapy with WT1 peptide vaccination for solid and hematological malignancies in children A Sawada, M Inoue, O Kondo - Pediatric blood & , 2016 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/pbc.25792H-SLFNTIATL-OH
Peptide H-SLFNTIATL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-SLFNTIATL-OH include the following: CTL epitope distribution patterns in the Gag and Nef proteins of HIV-1 from subtype A infected subjects in Kenya: use of multiple peptide sets increases the detectable JR Currier, U Visawapoka, S Tovanabutra, CJ Mason - BMC immunology, 2006 - Springerhttps://link.springer.com/article/10.1186/1471-2172-7-8H-FFVAPFPEVF^GK-OH
Peptide H-FFVAPFPEVF^GK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-FFVAPFPEVF^GK-OH include the following: Casein-derived peptides with antihypertensive potential: Production, identification and assessment of complex formation with angiotensin I-converting enzyme (ACE) TV De Oliveira , MD Polacaªto , MR De Oliveira, TJ Silva - Food biophysics, 2020 - Springerhttps://link.springer.com/article/10.1007/s11483-019-09616-9 Structural and molecular bases of angiotensin-converting enzyme inhibition by bovine casein-derived peptides: an in silico molecular dynamics approach TV De Oliveira , AP Guimaraca£es - Journal of , 2021 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/07391102.2020.1730243 Whey proteins as source of bioactive peptides against hypertension TG Tavares, FX Malcata - Bioactive food peptides in health and , 2013 - books.google.comhttps://books.google.com/books?hl=en&lr=&id=FkueDwAAQBAJ&oi=fnd&pg=PA75&dq=(%22H-FFVAPFPEVF%5EGK-OH%22+OR+%22NH2-Phe-Phe-Val-Ala-Pro-Phe-Pro-Glu-Val-Phe%5EGly-Lys-OH%22+OR+%22FFVAPFPEVF%5EGK%22+OR+%22H-FFVAPFPEVFGK-OH%22+OR+%22FFVAPFPEVFGK%22)+AND+peptide&ots=by05qlyyp1&sig=VgNRhL-aJxzPy-YjAeIz-HeNt3k Reducing Effects of Whey Protein Hydrolysate on Coloration of Cured Sausages S Takeda , T Kanda, AM Ahhmed, K Sogawa, K Umezu - Foods, 2023 - mdpi.comhttps://www.mdpi.com/2304-8158/13/1/13 Self-assembling bioactive peptides for gastrointestinal delivery-Bioinformatics-driven discovery and in vitro assessment N Petit , JM Dyer , M Richena - Journal of Food , 2024 - Wiley Online Libraryhttps://ifst.onlinelibrary.wiley.com/doi/abs/10.1111/ijfs.17002 BBA Advances N Petit , JM Dyer , JA Gerrard , LJ Domigan , S Clerens - researchgate.nethttps://www.researchgate.net/profile/Noemie-Petit-2/publication/369306728_Insight_into_the_self-assembly_and_gel_formation_of_a_bioactive_peptide_derived_from_bovine_casein/links/643a6b88e881690c4bd7a663/Insight-into-the-self-assembly-and-gel-formation-of-a-bioactive-peptide-derived-from-bovine-casein.pdf Insight into the self-assembly and gel formation of a bioactive peptide derived from bovine casein N Petit , JM Dyer , JA Gerrard , LJ Domigan , S Clerens - BBA advances, 2023 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S2667160323000157 The potential role of milk-derived peptides in cardiovascular disease M Phelan, D Kerins - Food & Function, 2011 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2016/fo/c1fo10017c Measuring the angiotensin-converting enzyme inhibitory activity of an 8-amino acid (8mer) fragment of the C12 antihypertensive peptide M Paul, JG Phillips, JA Renye Jr - Journal of dairy science, 2016 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0022030216300522 Casein Fermentate of Lactobacillus animalis DPC6134 Contains a Range of Novel Propeptide Angiotensin-Converting Enzyme Inhibitors M Hayes , C Stanton , H Slattery - Applied and , 2007 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/aem.00096-07 Enzymatic Degradation of Allergen Peptides from Bovine Casein by a Combination of Streptomyces Aminopeptidases K Wan, M Uraji, S Tokai, T Hatanaka - Applied biochemistry and , 2019 - Springerhttps://link.springer.com/article/10.1007/s12010-018-2839-7 Novel activity of Streptomyces aminopeptidase P K Wan, M Uraji, L Yang, R Nakahigashi - Bioresources and , 2020 - Springerhttps://link.springer.com/article/10.1186/s40643-020-00309-7 Identification, inhibition modes, and molecular docking of ACE inhibitory peptides derived from Cheddar cheese J Qiu, M Xu, R Ren, Y Zhao, L Liu, X Li, X Zhu, H Ji - LWT, 2024 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0023643824006054 Identification and screening of potential bioactive peptides with sleep-enhancing effects in bovine milk casein hydrolysate J Qian, L Zheng, G Su, M Huang , D Luo - Journal of Agricultural , 2021 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.jafc.1c03937 Manufacturing of peptides exhibiting biological activity A Zambrowicz, M Timmer, A Polanowski, G Lubec - Amino acids, 2013 - Springerhttps://link.springer.com/article/10.1007/s00726-012-1379-7H-CTLDEAERLTEEELH-OH
Peptide H-CTLDEAERLTEEELH-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-CTLDEAERLTEEELH-OH include the following: Calcium-sensing receptor regulation of PTH-inhibitable proximal tubule phosphate transport J Ba, D Brown , PA Friedman - American Journal of , 2003 - journals.physiology.orghttps://journals.physiology.org/doi/abs/10.1152/ajprenal.00249.2003TACC3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of TACC3 antibody, catalog no. 70R-4547Purity:Min. 95%N,N-Diisopropylcarbodiimide
CAS:Formula:C7H14N2Purity:99%Color and Shape:LiquidMolecular weight:126.1995Ref: IN-DA0035B8
5g21.00€10g21.00€1kg158.00€25g25.00€5kg528.00€100g39.00€10kgTo inquire250g71.00€500g109.00€EVI1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of EVI1 antibody, catalog no. 70R-4771Purity:Min. 95%H-NTLYLQMNSLR^-OH
Peptide H-NTLYLQMNSLR^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-NTLYLQMNSLR^-OH include the following: Rapid characterization of a emicizumab, a bispecific mono-clonal antibody using a CESI 8000-TripleTOF 6600 System Z Szabo, A Guttman - sciex.com.cnhttps://www.sciex.com.cn/content/dam/SCIEX/pdf/tech-notes/biopharma/cesi-ms-tn-bispecifics.pdf Detecting low level sequence variants in recombinant monoclonal antibodies Y Yang, A Strahan, C Li, A Shen, H Liu, J Ouyang - MAbs, 2010 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.4161/mabs.2.3.11718 Pharmacokinetics and Metabolism: Analysis of Low-abundant Deamidation and Oxidation Modifications in Therapeutic Species in Complex Biological Matrices by SC Mena Perez - 2021 - ediss.sub.uni-hamburg.dehttps://ediss.sub.uni-hamburg.de/handle/ediss/9495 High-resolution MS for structural characterization of protein therapeutics: advances and future directions H Wei, AA Tymiak, G Chen - Bioanalysis, 2013 - Future Sciencehttps://www.future-science.com/doi/abs/10.4155/bio.13.80L-Proline Methyl Ester Hydrochloride
CAS:Formula:C6H11NO2·HClPurity:>98.0%(T)Color and Shape:White to Almost white powder to crystalMolecular weight:165.62C12ORF24 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of C12orf24 antibody, catalog no. 70R-3636Purity:Min. 95%ARPP-21 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ARPP-21 antibody, catalog no. 70R-2326Purity:Min. 95%EVX2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of EVX2 antibody, catalog no. 70R-8467Purity:Min. 95%IQCK Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of IQCK antibody, catalog no. 70R-4181Purity:Min. 95%Tyrosinase (243-251) (human)
Custom research peptide; min purity 95%.Formula:C44H68N10O18S2Purity:Min. 95%Molecular weight:1,089.2 g/molPotassium 2-(phenylamino)acetate
CAS:Formula:C8H8KNO2Purity:98%Color and Shape:SolidMolecular weight:189.2529H-NSHTIMQIQCK-OH
Peptide H-NSHTIMQIQCK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-NSHTIMQIQCK-OH include the following: Discovery of a potent and isoform-selective targeted covalent inhibitor of the lipid kinase PI3Kalpha M Nacht, L Qiao, MP Sheets, T St. Martin - Journal of medicinal , 2013 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/jm3008745 Discovery of an irreversible PI3Kalpha-specific Inhibitor L Qiao, M Nacht, MP Sheets, TS Martin - Cancer , 2011 - media2.celgene.comhttps://media2.celgene.com/content/uploads/pdf/PI3Ka_poster_AACR20110406.pdf Covalent proximity scanning of a distal cysteine to target PI3Kalpha C Borsari , E Keles, JA McPhail - Journal of the , 2022 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/jacs.1c13568PARP11 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PARP11 antibody, catalog no. 70R-2103Purity:Min. 95%H-TVEGAGSIAAATGFVK^-OH
Peptide H-TVEGAGSIAAATGFVK^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-TVEGAGSIAAATGFVK^-OH include the following: Absolute quantification of synuclein proteoforms in plasma in patients with Synucleinopathies by LC-MRM mass spectrometry ML PONS, M Vignon, J Vialaret , E Mondesert - medRxiv, 2023 - medrxiv.orghttps://www.medrxiv.org/content/10.1101/2023.07.17.23292753.abstract An alpha-synuclein MRM assay with diagnostic potential for Parkinson's disease and monitoring disease progression L Yang, T Stewart, M Shi , G Pottiez - PROTEOMICS , 2017 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/prca.201700045 Analysis of alpha-synuclein in malignant melanoma-development of a SRM quantification assay C Welinder , GB Jönsson , C Ingvar , L Lundgren - PloS one, 2014 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0110804 Establishing a Southern Swedish Malignant Melanoma OMICS and biobank clinicalcapability C Welinder , G Jönsson , C Ingvar , L Lundgren - Clinical and translational , 2013 - Springerhttps://link.springer.com/article/10.1186/2001-1326-2-7 Low-expressing synucleinopathy mouse models based on oligomer-forming mutations and C-terminal truncation of alpha-synuclein A Martinez Hernandez, I Silbern , I Geffers - Frontiers in , 2021 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fnins.2021.643391/full alpha-Synuclein aggregation in the saliva of familial transthyretin amyloidosis: a potential biomarker A Guerreiro , G da Costa, RA Gomes , C Ribeiro-Silva - Amyloid, 2012 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.3109/13506129.2012.668500β-Amyloid (1-17)
CAS:This synthetic peptide consists of amino acids 1 to 17 of beta amyloid protein. This peptide can be employed in beta amyloid solubility studies.Formula:C90H130N28O29Purity:98%Color and Shape:SolidMolecular weight:2068.2Histone H2A (1-20)-GGK(Biotin)
The Histone H2A residues 1 to 20 are derived from histone 2A (H2A) which is one of the four core histones (H2A, H2B, H3 and H4) fundamental in compacting eukaryotic DNA into a structure known as the nucleosome. The nucleosome arises when 147 base pairs of DNA wrap around a H3-H4 tetramer and two H2A-H2B dimers, forming the histone octamer core.At the site of DNA entry on the outer nucleosome, the C-terminus of H2A is present and is able to interact with linker histones or other factors. This allows for variation and changes in nucleosome stability to occur. Furthermore Histone H2A has histone variants such as H2A.Z and H2A.X (which are present in all organisms) and these variants alter the organisation of the DNA.Due to histones containing a large number of lysine and arginine residues they have a positive net charge which interacts in an electrostatic manner with the negatively charged phosphate groups in DNA. The transcriptional activation or silencing of the chromatin is controlled by ATP-dependent chromatin remodelling factors and histone modifying enzymes which target histone proteins. Both processes function to alter to change the positioning of the nucleosome, allowing the DNA it to be either available to the transcription machinery or inaccessible.Biotin has been added to the lysine on GGK.Molecular weight:898.5 g/molSomatostatin 14
CAS:Somatostatin is used as a growth hormone-release inhibiting factor, treatment of severe, acute hemorrhage of gastroduodenal ulcers, experimental antidiabetic. This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.Formula:C76H104N18O19S2Molecular weight:1637.89PPAT Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PPAT antibody, catalog no. 70R-2079Purity:Min. 95%H-NNNN-NH2
Peptide H-NNNN-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-NNNN-NH2 include the following: Immunoreactivities Caused by Certain Amino Acid Substitutions in a Short Peptide and Possible Effects of Differential Refolding of the Peptide on a Nitrocellulose or T Yamamoto , T Matsuo, A Yamamoto - Peptide Antibodies , 2015 - Springerhttps://link.springer.com/protocol/10.1007/978-1-4939-2999-3_26 Rotating ring-disk electrode study of copper (II) complexes of the model peptides triglycine, tetraglycine, and pentaglycine SJ Woltman, MR Alward, SG Weber - Analytical chemistry, 1995 - ACS Publicationshttps://pubs.acs.org/doi/pdf/10.1021/ac00099a010 Redox behaviors of the neurotoxic portion in human prion protein, HuPrP (106-126) N Yamamoto, K Kuwata - Chemical Physics Letters, 2010 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0009261410011309 Spectroscopic and potentiometric evidence for the stabilization of a bent structure of octapeptides by Cu (II) ions M Bataille, LD Pettit, I Steel, H Kozlowski - Journal of inorganic , 1985 - Elsevierhttps://www.sciencedirect.com/science/article/pii/0162013485850042 Influence of the proline residue on the co-ordination of Cu (II) to peptides containing-Pro-and-Pro-Pro-subunits LD Pettit, C Livera, I Steel, M Bataille, C Cardon - Polyhedron, 1987 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0277538700812371 Gas-phase complexes of Ni2+ and Ca2+ with deprotonated histidylhistidine (HisHis): A model case for polyhistidyl-metal binding motifs K Peckelsen, J Martens , G Berden , J Oomens - Journal of Molecular , 2017 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0022285216302806 Effect of peptide primary sequence on biuret complex formation and properties JG Chen, M Logman, SG Weber - : An International Journal , 1999 - Wiley Online Libraryhttps://analyticalsciencejournals.onlinelibrary.wiley.com/doi/abs/10.1002/(SICI)1521-4109(199905)11:5%3C331::AID-ELAN331%3E3.0.CO;2-%233-Isoquinolinecarboxylic acid, 1,2,3,4-tetrahydro-, (3S)-
CAS:Formula:C10H11NO2Purity:98%Color and Shape:SolidMolecular weight:177.19983999999997Ac-Nle-Cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2
CAS:Ac-Nle-Cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, also known as cycloastragenol, is a synthetic cyclic peptide that inhibits the activity of adipose β3 adrenergic receptors, leading to reduced fat accumulation. Cycloastragenol has been shown to inhibit the formation of atherosclerotic lesions in mice and may have antiatherogenic effects. It also has been shown to inhibit tumor growth in some skin cancer models and has immunosuppressive effects. The following product descriptions are for a fictional company called "Fluorochem."Formula:C50H69N15O9Purity:Min. 95%Molecular weight:1,024.2 g/molSecernin 2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SCRN2 antibody, catalog no. 70R-4388Purity:Min. 95%(D-Trp12,Tyr34)-pTH (7-34) amide (bovine) acetate
D-Trp12,Tyr34-pTH(7-34) (bovine) is a PTH antagonist with a Ki of 69 nM in bovine kidneys.Purity:96.84%Color and Shape:LiquidMolecular weight:N/AMatrilin 1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of MATN1 antibody, catalog no. 70R-5353Purity:Min. 95%HAEGTFTSD
CAS:HAEGTFTSD is GLP-1's initial segment; GLP-1 (7-36) amide, tied to food intake, stems from preproglucagon in L-cells.Formula:C40H57N11O17Purity:98%Color and Shape:SolidMolecular weight:963.94IKZF2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of IKZF2 antibody, catalog no. 70R-9568Purity:Min. 95%H-RFPLTFGWCF-OH
Peptide H-RFPLTFGWCF-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-RFPLTFGWCF-OH include the following: Can glycosylation mask the detection of MHC expressing p53 peptides by T cell receptors? TB Nguyen , DP Lane , CS Verma - Biomolecules, 2021 - mdpi.comhttps://www.mdpi.com/2218-273X/11/7/1056 Different abilities of escape mutant-specific cytotoxic T cells to suppress replication of escape mutant and wild-type human immunodeficiency virus type 1 in new hosts M Fujiwara, J Tanuma, H Koizumi - Journal of , 2008 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.01452-07DADPS Biotin Azide
CAS:This reagent contains a biotin moiety linked to an azide moiety through a spacer arm containing a cleavable DADPS linker. Captured biomolecules can be efficiently released under mild conditions (10% formic acid, 0.5 h) and the small molecular fragment (143 Da) left on the labeled protein following cleavage.Formula:C43H67N7O9SSiPurity:>95% (Hplc)Color and Shape:PowderMolecular weight:886.19 g/molGlycine, N-benzoyl-, monosodium salt
CAS:Formula:C9H8NNaO3Purity:97%Color and Shape:SolidMolecular weight:201.15449000000004H-GLLCYCRKGHCKRGERVRGTCGIRFLYCCPRR-OH
Peptide H-GLLCYCRKGHCKRGERVRGTCGIRFLYCCPRR-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice.N-(tert-Butoxycarbonyl)-L-2-phenylglycine
CAS:Formula:C13H17NO4Purity:>98.0%(HPLC)Color and Shape:White to Almost white powder to crystalMolecular weight:251.28ASF1B Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ASF1B antibody, catalog no. 70R-2065VAT1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of VAT1 antibody, catalog no. 70R-4508Purity:Min. 95%Glycogen Synthase 2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of GYS2 antibody, catalog no. 70R-2872Purity:Min. 95%CDH7 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CDH7 antibody, catalog no. 70R-6178Purity:Min. 95%H-ASYPGLQFEIIAMSTTGDK^-OH
Peptide H-ASYPGLQFEIIAMSTTGDK^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-ASYPGLQFEIIAMSTTGDK^-OH include the following: Systemic messenger RNA as an etiological treatment for acute intermittent porphyria L Jiang, P Berraondo , D Jerico, LT Guey - Nature medicine, 2018 - nature.comhttps://www.nature.com/articles/s41591-018-0199-z Recombinant porphobilinogen deaminase targeted to the liver corrects enzymopenia in a mouse model of acute intermittent porphyria KM Cordoba, I Serrano-Mendioroz, D Jerico - Science Translational , 2022 - science.orghttps://www.science.org/doi/abs/10.1126/scitranslmed.abc0700 Systemic messenger RNA as an etiological treatment for acute intermittent porphyria A Fontanellas-Roma, P Martini, MA Avila, CM Lukacs - 2018 - dadun.unav.eduhttps://dadun.unav.edu/handle/10171/68674 Recombinant porphobilinogen deaminase targeted to the liver corrects enzymopenia in a mouse model of acute intermittent porphyria A Fontanellas-Roma, KM Cordoba-Quines - 2022 - dadun.unav.eduhttps://dadun.unav.edu/handle/10171/68666Pep1-AGL
Analog of Pep1-TGLFormula:C40H69N11O14SPurity:98%Color and Shape:SolidMolecular weight:960.11Defensin HNP-3 (human)
CAS:Custom research peptide; min purity 95%. For different specs please use the Peptide Quote ToolFormula:C151H222N44O40S6Molecular weight:3,486.09 g/molDiazepam-Binding Inhibitor Fragment, Human
This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.LCBiot-NAPVISPQ-OH
Peptide LCBiot-NAPVISPQ-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using LCBiot-NAPVISPQ-OH include the following: Using Zebrafish as a Model System for Studying the Autism Risk Gene adnp in Early Embryonic Development W Theune - 2021 - digitalcommons.newhaven.eduhttps://digitalcommons.newhaven.edu/masterstheses/177/ Differential expression of embryonic and maternal activity-dependent neuroprotective protein during mouse development SH Poggi , J Vink, K Goodwin, JM Hill - American journal of , 2002 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0002937802002806 Editorial [Hot topic: VIP and PACAP: Novel Approaches to Brain Functions and Neuroprotection (Executive Guest Editors: Seiji Shioda and Illana Gozes)] S Shioda, I Gozes - Current pharmaceutical design, 2011 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/cpd/2011/00000017/00000010/art00001 NAP mechanisms of neuroprotection I Gozes , RA Steingart, AD Spier - Journal of Molecular Neuroscience, 2004 - Springerhttps://link.springer.com/article/10.1385/JMN:24:1:067 A novel VIP responsive gene: activity dependent neuroprotective protein I Gozes , R Zamostiano, A Pinhasov - Annals of the New , 2000 - Wiley Online Libraryhttps://nyaspubs.onlinelibrary.wiley.com/doi/abs/10.1111/j.1749-6632.2000.tb06957.xAnti PHI (Rat) Serum
Anti PHI (Rat) Serum is a research tool that can be used in antibody detection, receptor binding, cell biology, ion channels and pharmacology. It is a high purity product with a CAS number of 613-12-5.Purity:Min. 95%H-SLGPALLLLQK^-OH
Peptide H-SLGPALLLLQK^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-SLGPALLLLQK^-OH include the following: Multiplexed targeted mass spectrometry assays for prostate cancer-associated urinary proteins T Shi , SI Quek , Y Gao , CD Nicora , S Nie , TL Fillmore - Oncotarget, 2017 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731921/ Development of a Multimarker Urine Test for Prostate Cancer AY Liu - 2017 - apps.dtic.milhttps://apps.dtic.mil/sti/citations/AD1048555Type A Allatostatin I
CAS:Type A Allatostatin I: tridecapeptide, inhibits juvenile hormone synthesis in insects, pleiotropic neuropeptide.Formula:C61H94N18O16Purity:98%Color and Shape:SolidMolecular weight:1335.511-Naphthalenylsulfonyl-Ile-Trp-aldehyde
CAS:1-Naphthalenylsulfonyl-Ile-Trp-aldehyde is a recombinant protein that has protease activity. It is a serine protease that cleaves proteins at the amino acid sequence Ser-Xaa-Gly or Ser-Xaa. The recombinant protein has been shown to have proteolytic activity and can be used in assays to measure the amount of β-catenin, collagen, and growth factor in cells. 1-Naphthalenylsulfonyl-Ile-Trp-aldehyde also binds to monoclonal antibodies and can be used as a neutralizing agent for these proteins. This recombinant protein also has been shown to inhibit the growth of lung fibroblasts.Formula:C27H29N3O4SPurity:Min. 95%Color and Shape:PowderMolecular weight:491.6 g/molH-YDVDTLDMVFLDHWK^-OH
Peptide H-YDVDTLDMVFLDHWK^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-YDVDTLDMVFLDHWK^-OH include the following: Assess of catechol-O-methyltransferase soluble isoform by multiple reaction monitoring mass spectrometry JMS Diogo - 2016 - search.proquest.comhttps://search.proquest.com/openview/ad859c269e17145b511a08fe8d7f0118/1?pq-origsite=gscholar&cbl=2026366&diss=yH-KELYPLTSL-OH
Peptide H-KELYPLTSL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-KELYPLTSL-OH include the following: Proteolysis of mature HIV-1 p6 Gag protein by the insulin-degrading enzyme (IDE) regulates virus replication in an Env-dependent manner F Hahn, A Schmalen , C Setz, M Friedrich, S Schlößer- PloS one, 2017 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0174254 Molecular mechanisms of HIV-1 mother-to-child transmission and infection in neonatal target cells N Ahmad - Life sciences, 2011 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S002432051000411X Important contribution of p15 Gag-specific responses to the total Gag-specific CTL responses GY Xu , H Shang, MM Addo , RL Eldridge, MN Phillips- Aids, 2002 - journals.lww.comhttps://journals.lww.com/aidsonline/fulltext/2002/02150/important_contribution_of_p15_gag_specific.2.aspx Supplemental Table 1. List of HIV class I peptides. M End - pdfs.semanticscholar.orghttps://pdfs.semanticscholar.org/ed0f/0f087694817c860c5aad97fab618403c2847.pdfARV1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ARV1 antibody, catalog no. 70R-6453Purity:Min. 95%MLC-derived peptide
Catalogue peptide; min. 95% purityFormula:C70H115N25O17Molecular weight:1,578.85 g/molZNF488 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF488 antibody, catalog no. 70R-8442Purity:Min. 95%3-PHTHALIMIDOPROPIONIC ACID
CAS:Formula:C11H9NO4Purity:98%Color and Shape:SolidMolecular weight:219.1935α-Mating Factor, yeast
CAS:This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.Formula:C82H114N20O17SMolecular weight:1684.2UBE4B Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of UBE4B antibody, catalog no. 70R-2330Purity:Min. 95%RTDR1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of RTDR1 antibody, catalog no. 70R-3551Purity:Min. 95%Acd Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of Acd antibody, catalog no. 70R-8190Purity:Min. 95%Ipamorelin 2 Pivalic acid
Ipamorelin 2 Pivalic acid (NNC-26-0161) is a growth-hormone-releasing peptide, induces longitudinal bone growth in rats.Formula:C38H49N9O5·2C5H10O2Purity:100%Color and Shape:SolidMolecular weight:916.12HLA-DRB1*1501 peptide
The HLA-DRB1*1501 peptide, is encoded by the disease-associated MHC allele histocompatibility leukocyte antigen (HLA)-DRB1*1501 which is present on the MHC region of chromosome 6. The increased frequency of the HLA-DRB*11501 haplotype found in Multiple Sclerosis (MS) patients, may contribute to the MS phenotype through disrupting T cell repertoire selection and through the presentation of self-peptides which can be targeted by the body's autoimmune response. Moreover studies investigating the accumulation of amyloid β-peptide (Aβ) as a factor producing Alzheimer's disease (AD) pathogenicity, found that HLA-DR alleles such as DRB1*1501 demonstrate immunogenic properties. It is evident that the DRB1*1501 halotype is associated with strong Aβ-T cell responses resulting in the large production of IFN- γ and IL-17. Therefore the HLA-DRB1*1501 peptide would be beneficial in studies exploring the phenotypes of autoimmune-diseases like MS and AD.Purity:Min. 95%Color and Shape:PowderMolecular weight:1,568.7 g/molSyntide 2
CAS:Syntide-2 is a synthetic peptide recognized as a substrate by Ca2+/calmodulin-dependent protein kinase II (CaMKII; Km = 12 µM).Formula:C68H122N20O18Purity:98%Color and Shape:Lyophilized SolidMolecular weight:1507.82RB1CC1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of RB1CC1 antibody, catalog no. 70R-8905Purity:Min. 95%ApoB Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of APOB antibody, catalog no. 70R-7483Purity:Min. 95%Hemoglobin β chain [133-146]
Custom research peptide; min purity 95%. For different specs please use the Peptide Quote ToolFormula:C66H104N20O17Molecular weight:1,449.6 g/molClaudin 13 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CLDN13 antibody, catalog no. 70R-1681Purity:Min. 95%m-dPEG®2-Tosylate
m-dPEG®2-Tosylate is a PEG compound with two different functional groups (also known as heterobifunctional). Unlike homobifunctional PEG compounds (same functional group on both ends), this type of compounds are more versatile as have two different anchor points. m-dPEG®2-Tosylate is used as a linker and spacer to add a PEG moiety, via pegylation (a bioconjugation technique) to proteins, peptides, oligonucleotides, small molecules and nanoparticles.Purity:Min. 95%H-PDSLRDLSVF-OH
Peptide H-PDSLRDLSVF-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-PDSLRDLSVF-OH include the following: Robust antigen-specific CD8 T cell tolerance to a model prostate cancer neoantigen ZA Lopez-Bujanda , MG Chaimowitz - , 2020 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/2162402X.2020.1809926 Coexpression of Flt3 ligand and GM-CSF genes modulates immune responses induced by HER2/neu DNA vaccine YT Yo, KF Hsu, GS Shieh, CW Lo , CC Chang - Cancer Gene , 2007 - nature.comhttps://www.nature.com/articles/7701081 Adjuvant effect of HER-2/neu-specific adenoviral vector stimulating CD8+ T and natural killer cell responses on anti-HER-2/neu antibody therapy for well-established Y Chen, Y Xie, T Chan, A Sami , S Ahmed , Q Liu - Cancer Gene , 2011 - nature.comhttps://www.nature.com/articles/cgt201118 HER-2/neu-gene engineered dendritic cell vaccine stimulates stronger HER-2/neu-specific immune responses compared to DNA vaccination T Chan, A Sami , A El-Gayed, X Guo , J Xiang - Gene therapy, 2006 - nature.comhttps://www.nature.com/articles/3302797 Vaccination of fiber-modified adenovirus-transfected dendritic cells to express HER-2/neu stimulates efficient HER-2/neu-specific humoral and CTL responses and S Sas, T Chan, A Sami , A El-Gayed, J Xiang - Cancer Gene Therapy, 2008 - nature.comhttps://www.nature.com/articles/cgt200818 OX40 costimulation synergizes with GM-CSF whole-cell vaccination to overcome established CD8+ T cell tolerance to an endogenous tumor antigen S Murata, BH Ladle, PS Kim , ER Lutz - The Journal of , 2006 - journals.aai.orghttps://journals.aai.org/jimmunol/article/176/2/974/73631 Chronic immune therapy induces a progressive increase in intratumoral T suppressor activity and a concurrent loss of tumor-specific CD8+ T effectors in her-2/neu RE Nair, MO Kilinc, SA Jones - The Journal of , 2006 - journals.aai.orghttps://journals.aai.org/jimmunol/article/176/12/7325/7501 Vaccination Strategy Determines the Emergence and Dominance of CD8+ T-Cell Epitopes in a FVB/N Rat HER-2/neu Mouse Model of Breast Cancer R Singh, Y Paterson - Cancer research, 2006 - AACRhttps://aacrjournals.org/cancerres/article-abstract/66/15/7748/525995 In the FVB/N HER-2/neu transgenic mouse both peripheral and central tolerance limit the immune response targeting HER-2/neu induced by Listeria monocytogenes R Singh, Y Paterson - Cancer Immunology, Immunotherapy, 2007 - Springerhttps://link.springer.com/article/10.1007/s00262-006-0237-4 Fusion to Listeriolysin O and delivery by Listeria monocytogenes enhances the immunogenicity of HER-2/neu and reveals subdominant epitopes in the FVB/N mouse R Singh, ME Dominiecki, EM Jaffee - The Journal of , 2005 - journals.aai.orghttps://journals.aai.org/jimmunol/article/175/6/3663/73302 Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein P Cheng , CA Corzo, N Luetteke, B Yu - The Journal of , 2008 - rupress.orghttps://rupress.org/jem/article-abstract/205/10/2235/47046 In vivo antitumor function of tumor antigen-specific CTLs generated in the presence of OX40 co-stimulation in vitro N Pham Minh, S Murata, N Kitamura - Journal of Cancer, 2018 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.31244 Booster immunizations with DNA plasmids encoding HER-2/neu prevent spontaneous mammary cancer in HER-2/neu transgenic mice over life span M Provinciali , A Barucca, F Orlando , E Pierpaoli - Scientific reports, 2017 - nature.comhttps://www.nature.com/articles/s41598-017-03286-8 In vivo electroporation restores the low effectiveness of DNA vaccination against HER-2/neu in aging M Provinciali , A Barucca, E Pierpaoli, F Orlando - Cancer Immunology , 2012 - Springerhttps://link.springer.com/article/10.1007/s00262-011-1107-2 Exosomal pMHC-I complex targets T cell-based vaccine to directly stimulate CTL responses leading to antitumor immunity in transgenic FVBneuN and HLA-A2/HER2 L Wang, Y Xie, KA Ahmed , S Ahmed, A Sami - Breast cancer research , 2013 - Springerhttps://link.springer.com/article/10.1007/s10549-013-2626-7 Strategy for Identifying Dendritic Cell-Processed CD4+ T Cell Epitopes from the HIV Gag p24 Protein L Bozzacco, H Yu, J Dengjel , C Trumpfheller - PloS one, 2012 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0041897 Strategy for Identifying Dendritic Cell-Processed CD4+ T Cell Epitopes from the L Bozzacco, H Yu, J Dengjel , C Trumpfheller - 2012 - academia.eduhttps://www.academia.edu/download/88232109/7daa33128524a46b1c98748cf0f66ce9dab5.pdf A STING agonist given with OX40 receptor and PD-L1 modulators primes immunity and reduces tumor growth in tolerized mice JB Foote, M Kok, JM Leatherman , TD Armstrong - Cancer immunology , 2017 - AACRhttps://aacrjournals.org/cancerimmunolres/article-abstract/5/6/468/468831 Combined Rho-kinase inhibition and immunogenic cell death triggers and propagates immunity against cancer GH Nam , EJ Lee , YK Kim, Y Hong , Y Choi - Nature , 2018 - nature.comhttps://www.nature.com/articles/s41467-018-04607-9 Co-expression of Flt-3 ligand gene ablates tumor immunity elicited by HER-2/neu DNA vaccine in transgenic mice FM Venanzi, A Barucca, K Havas, M Capitani - Vaccine, 2010 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X10003464 Dissecting the Mechanisms of T Cell Tolerance for More Effective Breast Cancer Vaccine Development PRINCIPAL INVESTIGATOR: Brian H. Ladle EM Jaffee - 2003 - apps.dtic.milhttps://apps.dtic.mil/sti/pdfs/ADA420387.pdf CXCL12/CXCR4 blockade induces multimodal antitumor effects that prolong survival in an immunocompetent mouse model of ovarian cancer E Righi, S Kashiwagi , J Yuan, M Santosuosso - Cancer research, 2011 - AACRhttps://aacrjournals.org/cancerres/article-abstract/71/16/5522/567664 tumor immune responses and delay of tumor development in human epidermal growth factor receptor 2 mice immunized with an immunostimulatory peptide in poly (D DF Campbell, R Saenz, IS Bharati, D Seible - Breast cancer , 2015 - Springerhttps://link.springer.com/article/10.1186/s13058-015-0552-9 Dissecting the Mechanism of T Cell Tolerance for More Effective Breast Cancer Vaccine Development BH Ladle, EM Jaffee - 2003 - apps.dtic.milhttps://apps.dtic.mil/sti/citations/tr/ADA435335 S REPORT DOCUMENTATION PAGE OMB No. 074-0188 BH Ladle, EM Jaffee - 2004 - apps.dtic.milhttps://apps.dtic.mil/sti/pdfs/ADA435335.pdf Listeria monocytogenes (Lm)-LLO immunotherapies reduce the immunosuppressive activity of myeloid-derived suppressor cells and regulatory T cells in the tumor A Wallecha, R Singh, I Malinina - Journal of immunotherapy, 2013 - journals.lww.comhttps://journals.lww.com/immunotherapy-journal/fulltext/2013/11000/Listeria_monocytogenes__Lm__LLO_Immunotherapies.3.aspxH-TPL^TATLSK^-OH
Peptide H-TPL^TATLSK^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-TPL^TATLSK^-OH include the following: The possibility of using the PlasmaDeepDiveâ¢MRM-panel in clinical diagnostics YV Miroshnichenko, NA Petushkova - ) Supplement Series B , 2015 - Springerhttps://link.springer.com/article/10.1134/S1990750815030051 Optimization of a human milk-directed quantitative sIgA ELISA method substantiated by mass spectrometry KA Dingess, P Van Dam, J Zhu , M Mank - Analytical and , 2021 - Springerhttps://link.springer.com/article/10.1007/s00216-021-03468-4 Quantitative determination of human IgA subclasses and their Fc-glycosylation patterns in plasma by using a peptide analogue internal standard and ultra-high HF Chen, CY Shiao, MY Wu, YC Lin - Rapid , 2020 - Wiley Online Libraryhttps://analyticalsciencejournals.onlinelibrary.wiley.com/doi/abs/10.1002/rcm.8606 Methods for quantification of immunological markers by mass spectrometry technique E BeneÅ¡ova - is.muni.czhttps://is.muni.cz/th/ugn6o/thesis_Benesova_final_public.pdfSpike S biotin protein library
Biotinylated version of the Spike (S) glycoprotein which corresponds to one of the leading targets for COVID-19 disease. Present on the surface of Sars-CoV-2 virus, Spike S protein is a class I fusion protein that allows the virus to enter host cells.BTG4 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of BTG4 antibody, catalog no. 70R-5595Purity:Min. 95%Troponin I Type 1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of TNNI1 antibody, catalog no. 70R-1250Purity:Min. 95%ARHGAP25 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ARHGAP25 antibody, catalog no. 70R-3021Purity:Min. 95%